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ABSTRACT. 
Lipopolysaccharides (LPS) are important structural components of the outer 
membrane of Gram-negative bacteria. Lipid A anchors LPS molecules in the outer 
membrane and is also the sole LPS component necessary for endotoxic shock 
induction. UDP-N-acetylglucosamine acyltransferase is encoded by the lpxA gene. In 
Escherichia coli K12 and Salmonella typhimurium, this enzyme completes the first 
step in lipid A synthesis. The lpxA gene product is essential for the production ofLPS 
in these organisms as null mutations in lpxA are lethal. The aim of the study was to 
characterise lipid A biosynthesis in Campylobacter jejuni. C. jejuni appears to contain 
three lipid A types, one of which is similar to the lipid A species in E. coli. In this 
study it was proposed that C. jejuni contains an enzyme that is functionally analogous 
to LpxA from E. coli. The initial aim was to clone the gene necessary for the 
production ofLpxA in C. jejuni. An E. coli temperature-sensitive mutant defective in 
LpxA activity provided a model with which to study the effect of acyltransferase 
deficiency on cell viability. A C. jejuni plasmid expression library was electroporated 
into E. coli lpxA mutant SMIOI cells and transformants were screened for their ability 
to survive at the previous non-permissive temperature (42°C) on minimal media 
containing ampicillin. Plasmid DNA from one transformant able to restore the full 
length LPS in lpxA defect in SMIOI was analysed. Nucleotide sequence has shown 
the gene order to be JabZ-lpxA as in E. coli and the predicted amino acid sequence 
from the 'lpxA' gene from C. jejuni displayed strong amino acid similarity to the 3' 
end of the UDP-N-acetylglucosamine acyltransferase protein from E. coli, S. 
typhimurium, Rickettsia rickettsii, Yersinia enterocolitica and Haemophilus 
inJluenzae. While this gene from C. jejuni F3 80 11 was capable of rescuing the 
temperature-sensitive defect of KLC 4177 (SMI 01), growth curves and viable plate 
counts reveal that rescue is not complete. A second allele of lpxA, cloned from C. 
jejuni strain NZRM 1958 has shown a similar arrangement of genes (fabZ-lpxA) 
although differences in primary amino acid sequence between the alleles were revealed. 
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CHAPTER I. 
INTRODUCTION. 
1.1 General Introduction. 
Campylobacter jejuni and related species have been known to be causative agents of 
human enterocolitis since the 1970's (Skirrow 1977), being first selectively isolated 
from the diarrhoeal stools of humans in 1972 (Butzler et al. 1973). In Britain and 
Wales, Campylobacter spp. are the most common enteric bacterial pathogen reported 
and have now overtaken Salmonella spp. as the principal cause of bacterial 
gastroenteritis (Jones and Telford 1991b; Southern et al. 1990; Humphrey 1995). 
Moreover, as disease caused by C. jejuni is not statutorily notifiable in Britain, the 
problem has the potential to be up to 100 times greater than indicated by the number of 
reported cases (Jones and Telford 1991b). Studies in other developed countries such 
as Australia, Belgium, Canada, the Netherlands, Sweden and the United States have 
shown C. jejuni in stools of 4%-14% of patients with diarrhoea and of <1% of 
asymptomatic persons (Blaser and Reller 1981). Studies in developing countries, such 
as Bangladesh, Peru, Rwanda, and The Gambia suggest that C. jejuni may be even 
more routinely isolated during diarrhoeal illness than in developed countries. However 
the rate of asymptomatic infection in these developing countries is often also very high 
(Blaser and Reller 1981; Blaser et al. 1983). This is suggestive of differences in 
infection rates in these two environments. Children in third world countries are 
constantly exposed to C. jejuni and thus may be living in an equilibrium with C. jejuni 
more so than people in the first world (Blaser and Reller 1981). From the first studies 
in the developing world, it was recognised that Campylobacter species could be 
isolated from children who were well as often as from children who had diarrhoea. In 
one study performed in Bangui, Central African Republic, 127 infants were monitored 
from birth to 6 months of age. Eighty-two Campylobacter infections were observed in 
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42% of the children, but there was no difference in isolation rates between children 
with and without diarrhoea (D. N. Taylor 1992). 
1.2 Campylobacter Biology. 
In New Zealand campylobacteriosis was made notifiable in 1981. Campylobacteriosis 
incidents are assumed to be the result of C. jejuni infection (Brieseman 1990) as C. 
jejuni is responsible for greater than 90% and Campylobacter coli for less than 10% of 
human infections. These two organisms are clinically indistinguishable and most 
laboratories do not routinely attempt to distinguish them (Nachamkin 1992). 
Campylobacter is the most commonly notified bacterial disease agent (Brieseman 
1990). Rates have been rising steadily from a national average of 14 cases per 100 000 
in 1981 to 150 cases per 100 000 in 1992, and 240 cases per 100 000 in 1993 
(Brieseman 1994). Infection rates in Canterbury are consistently higher than the rest 
of New Zealand with 291 cases per 100 000 in 1992 and 382 cases per 100 000 in 
1993 (Brieseman 1994). 
1.3 Description of the Genus. 
1.3.1 MORPHOLOGICAL OVERVIEW. 
The generic name Campylobacter comes from the Greek and means 'curved rod'. 
Members of the genus Campylobacter are seen as curved or helical rods 0.2-0.9 11m 
wide by 0.5-5 11m long. Campylobacter contain a single polar flagellum present at 
either one or both poles of the cell which provides motility to the organism. They are 
members of the Spirillum group, family Spirillaceae. Members of this genus are 
animal and human parasites. They are microaerophilic, unable to replicate in the level 
of oxygen present in air (21 %) and are generally cultured in a gaseous atmosphere 
containing 6% oxygen, 10% carbon dioxide, and 84% nitrogen. Skirrow et al. (1991; 
cited from Corry et al. 1995) reported that the presence of hydrogen at not less than 
7% improved the primary isolation of C. jejuni from faeces. 
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C. jejuni is able to survive in the aquatic environment in a viable but noncuIturable 
coccoid form (Rollins and Colwell 1986; Moran and Upton 1986). It is thought that 
this morphological transition is a survival adaptation for unfavourable environments 
and a great deal of interest has been generated in this area of physiology and the role of 
coccoid cells in disease transmission (Moran and Upton 1986). There is some 
evidence that C. jejuni is infectious to neonatal mice in this form, but this property may 
differ between strains (Jones et al. 1991a). 
1.3.2 EPIDEMIOLOGY. 
The sources of Campylobacter infection have been studied extensively in the United 
States as well as in New Zealand (Tauxe 1992; Hasell 1994; Eberhart-Phillips 1995). 
Four sources account for nearly all epidemic cases: consumption of chicken and 
chicken products, unpasteurized milk, contact with pets and other animals, and impure 
water (Rollins and Colwell 1986; Jones et al. 1991a; Park et al. 1981; Smith and 
Muldoon 1974; Brieseman 1994; Doyle and Roman 1982; Lovett et al. 1983; 
Brieseman 1984; Altekruse et al. 1994). In addition, other food sources have also 
been implicated in Campylobacter infections including mushrooms, watermelon, 
papaya, and shellfish (Doyle and Schoeni 1986; Castillo and Escartin 1994; Wilson and 
Moore 1996). 
C. jejuni is carried as part of the intestinal flora of many cattle, sheep, pigs, dogs, cats, 
poultry and other animals with animal faeces representing a major source of 
contamination (Rosef et al. 1983; Weijtens et al. 1993; Brennhovd et al. 1992). C. 
jejuni has been isolated from birds such as crows, gulls, domestic pigeons, migratory 
ducks, sandhill cranes and Canada geese (Kapperud and Rosef 1983; Pacha 
et al. 1988). Houseflies can also act as vectors for C. jejuni (Rosef and Kapperud 
1983). There is some evidence to link contact with puppies and kittens to 
campylobacteriosis, especially to children (Hasell 1994). In another case study, the 
rise in the rate of C. jejuni infection was attributed to the consumption or handling of 
milk that had been attacked by birds, such as magpies and jackdaws (Southern et al. 
1990). 
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1.3.3 TEMPERATURE AND STRESS. 
Most Campylobacter species have an optimum replication temperature of 30 to 37°C. 
C. jejuni, C. coli, C. lari and C. upsaliensis are exceptions in that optimum replication 
rates occur at 42°C and thus they are considered to be thermophilic. Paradoxically, 
Campylobacter spp. survive storage at refrigerated temperatures better than at room 
temperature (National Advisory Committee on Microbiological Criteria for Foods 
1995). Cells are sensitive to freezing, drying and to salt concentrations above 1 % 
sodium chloride (National Advisory Committee on Microbiological Criteria for Foods 
1995). Campylobacter spp. are sensitive to standard concentrations of common 
disinfectants, and C. jejuni is also sensitive to ultraviolet and gamma irradiation 
(National Advisory Committee on Microbiological Criteria for Foods 1995). 
Campylobacter spp. do not form spores, however as previously mentioned, may 
undergo a morphological transition to coccoid cells over time or under stress (Jones et 
al. 1991a; Griffins 1993; Boucher et al. 1994). 
The most frequently isolated Campylobacter spp. with regard to human enteric 
pathogens are C. jejuni, C. fetus, C. coli, and C. lari (Walker et al. 1986; Skirrow 
1977; Faoagali 1984; Stanier et al. 1984; Nachamkin 1992; National Advisory 
Committee on Microbiological Criteria for Foods 1995). C. jejuni is so called because 
it was first isolated from the jejunum of calves with diarrhoea in 1931 (Rees et al. 
1993). 
1.3.4 THE GENETICS OF Campylobacter SPECIES. 
Campylobacter spp. have a small genome of about 1600-1800 kb, an exception being 
C. upsaliensis with a genome of approximately 2000 kb, which is the largest 
Campylobacter genome recognised to date (Bourke et al. 1995). C. jejuni and C. coli 
genomes are only 36% of the size of the Escherichia coli chromosome (4600 kb) 
(Smith et al. 1987). The chromosome of C. jejuni is circular and approximately 1700 
kb in circumference (Nuijten et al. 1990; Chang and Taylor 1990; Kim et al. 1992). 
The DNA is extremely AT-rich with a mol % GC of approximately 30% compared 
with the genome of E. coli, which has a mol % GC of 50% (Chang and Taylor 1990; 
Kim et al. 1992; Kim et al. 1993). The small genome size of Campylobacter spp. is 
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consistent with their small and fastidious nature; these organisms require numerous 
supplements for growth, cannot ferment most ordinary carbohydrates or degrade 
complex substances, and appear biologically inert (D. E. Taylor 1992). Conjugative 
plasmids and bacteriophages have been reported in campylobacters and these 
extrachromosomal elements may contain essential genes required by campylobacters 
due to their small genome (D. E. Taylor 1992). 
1.4 Campylobacter Diseases. 
1.4.1 PATHOLOGY AND CLINICAL SYMPTOMS OF CAMPYLOBACTERIOSIS. 
Once established C. jejuni infections in humans can manifest in several different forms. 
Symptomatic infection due to C. jejuni is shown by a gastrointestinal illness and is 
usually self-limited. Mild C. jejuni infections may produce symptoms similar to those 
during viral gastroenteritis and may only last for 24 hours (Blaser et al. 1983). 
However the illness can last up to three weeks, with an incubation period of 2-11 days 
(Skirrow 1977). Symptoms of Campylobacter gastroenteritis include diarrhoea (often 
bloody), nausea, fever, occasional vomiting, headache, malaise, muscular aches and 
pains, and acute abdominal pain (Stehr-Green et al. 1991; Eberhart-Phillips et al. 
1995) (Table 1). Many patients have at least one day with eight or more bowel 
movements. Acute abdominal pain in some circumstances may mimic acute 
appendicitis and may result in unnecessary surgery (Blaser and Reller 1981; Blaser et 
al. 1983). In one reported case, a patient with a suspected bowel perforation was 
operated upon, only to find inflammation of the ileum and colon. An unknown 
Campylobacter spp. was subsequently isolated from the diarrhoeal fluid (Skirrow 
1977). 
Most afllicted people recover in less than a week; however, the illness may follow a 
biphasic course, with up to 20% of cases undergoing a relapse or suffering from a 
prolonged or severe illness (Skirrow 1977; Blaser and Reller 1981; Blaser et al. 1983). 
Infrequently, death may occur in elderly or debilitated patients (Tauxe 1992; Blaser et 
al. 1983). Untreated patients may continue to excrete the organism in faeces for two 
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to three weeks but transmissibility is low. Chronic carriage is unknown in healthy 
people in industrialised countries (Skirrow 1990). 
Table 1: Frequency of symptoms reported by cases in the New Zealand multi-centre analysis of 
gastroenteritis induced by Campy/obacter (MAGIC) study (Adapted from Eberhart-Phillips et a/. 
1995). 
Symptoms 
Diarrhoea 
Stomach pains/cramps 
Fever 
Nausea 
Blood in stool 
Vomiting 
Headache 
Lethargic/tired 
Body aches and pains 
Number 
(n=621) 
612 
558 
454 
394 
219 
194 
152 
94 
68 
Percent 
(%) 
98.6 
89.9 
73.1 
63.4 
35.3 
31.3 
24.5 
15.1 
11.0 
Generally hundreds to thousands of bacteria are usually required for infection by 
C. jejuni. However, studies indicate that even low doses of C. jejuni can produce 
infection and illness in humans. In one milk-borne outbreak it was estimated that only 
about 500 organisms had caused infection (Jones and Telford 1991b), and in a separate 
study, the minimum number of C. jejuni ingested by volunteers was 800 organisms, 
and this resulted in diarrhoeal illness (Black et al. 1988). Campylobacter spp. that 
have been ingested can be killed by gastric acid. Conditions which reduce acidity in 
the stomach, such as gastric surgery or peptic ulcer treatment, increases a person's 
susceptibility to Campylobacter infection. Milk buffers gastric acid and thus fewer 
organisms are needed for infection. 
The incidence of infection follows a bimodal age distribution, with the highest 
incidence recorded in infants and young children with a second peak in young adults 20 
to 40 years of age (Nachamkin 1992). A seasonal pattern is also shown with increased 
notifications occurring during spring and summer for both the northern and southern 
hemispheres. 
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Campylobacter infections can be effectively treated with antibiotics if provided early 
enough during an infection. Erythromycin is the antibiotic of choice for several 
reasons including organism susceptibility, ease of administration, high host uptake, and 
the lack of serious toxicity to host. It can shorten the duration of illness in some cases 
by rapidly killing organisms, as seen by dramatic decreases in culturable counts of C. 
jejuni excreted in the faeces within 48 hours. However, erythromycin does not seem 
to prevent relapse or cure persistent illness. There is evidence that ciprofloxacin also 
kills campylobacters and works rapidly (Blaser and Reller 1981; Jones and Telford 
1991b; Wallis 1994). 
1.4.2 Campylobacter EXTRAINTESTINAL DISEASES. 
Extraintestinal infections caused by C. jejuni have been reported. C. jejuni may 
penetrate the intestinal wall and invade a patient's bloodstream. Ladron de Guevara et 
al. have reported 7 cases of bacteraemia caused by C. jejuni or C. coli (Ladron de 
Guevara et al. 1994). C. jejuni bacteraemia has also occurred after a bone marrow 
transplant (Hagensee et al. 1994). Other extraintestinal infections that may occur due 
to C. jejuni include septicaemia, urinary tract infection, cholecystitis, reactive arthritis, 
Reiter's syndrome (Walker et al. 1986), empyema, encephalopathy (Yuki et al. 1994), 
bursitis, endocarditis, peritonitis, erythema nodosom, pancreatitis, abortion and 
neonatal sepsis (Nachamkin 1992). C. jejuni has also recently been isolated from bone 
marrow (Ruiz-Arenas and Arroyo-Gomez 1994). Neurologic complications due to C. 
jejuni infections are infrequent, but some which do occur are meningitis, stroke, 
Guillain-Barre syndrome (GBS) and Miller-Fisher Syndrome (MFS), the latter two are 
forms of involuntary paralysis. 
Guillain-Barre Syndrome (GBS) has replaced polio as the most common cause of 
acute neuromuscular paralytic disease in the developed world (Ropper 1992; Rees et 
al. 1993; Yuan et al. 1993; Yuki et al. 1994). Up to two-thirds of GBS cases are 
preceded by symptoms of an infectious illness, most frequently of the respiratory or 
gastrointestinal tract (Rees et al. 1993; Rees et al. 1995b). Campylobacteriosis is the 
most common antecedent event associated with GBS (Rees et al. 1993; Mishu et al. 
1993; Kuroki et al. 1993; Rees et al. 1995a). In the United States GBS has an annual 
incidence of 1.7 per 100 000 people (Mishu et al. 1993) and this reflects the annual 
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incidence in most other parts of the world as well, with 1 to 2 per 100 000 members of 
a population suffering from GBS (Mishu and Blaser 1994). GBS usually occurs 1-3 
weeks after bacterial or viral infections (Ropper 1992). About a quarter of all patients 
require mechanical ventilation. GBS has a mortality rate of 1-18% and 20% suffer 
prolonged residual disability (Rees et al. 1993). C. jejuni has been recovered from 
Japanese patients with GBS, and most of these isolates belong to a single serotype, 
heat stable antigen (HS) 19 (88%). HS19 only accounts for 1-3% of all 
campylobacteriosis which suggests that certain Campylobacter serotypes are 
associated with this syndrome (Kuroki et al. 1993). It has been observed that LPS 
from some HS strains of C. jejuni mimic the structure of human gangliosides and this 
ganglioside mimicry is thought to be of significance in the aetiology of GBS (Aspinall 
et al. 1992; Aspinall et al. 1994a). Ganglioside-like structures have been identified at 
the terminal regions of the core oligosaccharide (OS) of the lipopolysaccharide (LPS) 
molecule (Aspinall et al. 1994b). OS structures which have human ganglioside GMl 
and GDla structures have been found in serostrains for serotypes HS4 and HS 19 
(Aspinall et al. 1992; Aspinall et al. 1994b; Yuki et al. 1994) and GM2-like OS 
structures occur in the LPS from serostrains for serotypes HS1, HS23 and HS36 
(Aspinall et al. 1992). A C. jejuni strain of serotype HS10 isolated from a patient 
suffering from MFS had an OS structure reflecting the terminal region of human 
ganglioside GD3 (Salloway et al. 1996). Chemical analysis of the LPS revealed that 
the core oligosaccharide had a terminal trisaccharide epitope consisting of two 
molecules of sialic acid linked to galactose, and this trisaccharide is also present in LPS 
cores of serotype HS14 strains from patients with GBS, but not in cores of 
nonneuropathic C. jejuni. This suggests a possible role for the trisaccharide in the 
etiology of neuropathies (Salloway et al. 1996). 
In the United States between 1982 and 1989, extraintestinal infections accounted for 
only 0.3% of all the isolates of Campylobacter. In another example, the frequency of 
extraintestinal infections due to C. jejuni was also very low at 0.62% (Ruiz-Arenas and 
Arroyo-Gomez 1994). 
C. jejuni is the most common enteric bacterial pathogen in the United States and New 
Zealand and notifications of campylobacteriosis have increased dramatically in many 
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countries including New Zealand since becoming mandatory (Hasell 1994). The 
increase in campylobacteriosis is usually attributed to improved laboratory isolation 
techniques for culturing Campylobacter and increased awareness of the disease within 
the community at large (Hasell 1994). However, campylobacteriosis incidence is still 
on the increase. If more patients are seeking medical attention, could it be due to the 
severity of the symptoms of campylobacteriosis compared to salmonellosis? Is 
C. jejuni, in comparison with other organisms, more capable of producing infection in 
immunocompromised hosts? These questions still remain to be answered. A 
possibility for the increased number of cases may be a change in the virulence or host 
adaptation of at least some strains of Campylobacter due to Campylobacter 
introduction into the human population through increased poultry consumption (Hasell 
1994). Human adapted strains could perhaps spread more readily to other humans 
than would poultry-adapted strains. In developing countries Campylobacter strains 
have been found that produce toxins which are not associated with strains from 
industrialised countries. This could indicate that strains may acquire some type of 
virulence factor. If this was associated with adaptation to a human host, then 
infections with increased severity could result in more people seeking medical help 
than before (Hasell 1994). 
1.5 Virulence and Virulence Factors. 
1.5.1 FLAGELLA AND OTHER PROTEINS. 
For a pathogenic bacterium to be successful, it must be able to invade a susceptible 
host; adhere to host tissue; avoid destruction by the host's immune system; and 
replicate and transmit progeny to a new, susceptible host. In most cases specific 
structures on the pathogen's surface are critical in adherence and avoidance. 
The mechanisms by which C. jejuni causes disease are poorly understood. Cell surface 
structures such as flagella, fimbriae and LPS have been implicated in the virulence of 
enteric pathogens, such as E. coli, Salmonella spp. and C. jejuni (Nikaido and Vaara 
1985; Walker et al. 1986; Preston et al. 1996; Somerville et al. 1996). 
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In this section I will discuss factors produced by Campylobacter spp. that are 
implicated or proven to be important for the pathogenicity of the organism. These 
factors (flagella, LPS, toxins, fimbriae and others) are briefly examined below. 
1.5.1.1 Flagella. 
As a result of pathological changes due to campylobacters colonising the intestine 
clinical symptoms are observed in patients, most notably in the form of diarrhoea. 
Campylobacter spp. are usually associated with food or water, and therefore must 
enter the host intestine by way of the stomach. C. jejuni must be able to survive the 
acid barrier of the stomach before they are able to proceed to the intestine and colonise 
the distal ileum and colon (Ketley 1995). This colonisation step requires the 
production of flagella, which are the best characterised virulence determinants of 
Campylobacter spp. Mutants without flagella and flagellated nonmotile strains have 
been found to be unable to colonise animal models (D. E. Taylor 1992). Unsheathed 
flagella are phase and antigenically variable and are highly immunogenic, with patients 
producing antibodies to the flagella shortly after infection (D.E. Taylor 1992). 
Microfilaments, coated pit formation and de novo bacterial protein synthesis for 
invasion are all suggested mechanisms and pathways by which campylobacters invade 
host cells, but none have been consistently involved in the process of invasion apart 
from the flagellum (Ketley 1995). 
The intestinal mucus layer is a major barrier to penetration by enteric organisms, but 
locomotion aided by the spiral shape of Campylobacter spp. is thought to facilitate 
penetration through this viscous layer (Walker et al. 1986). C. jejuni has the unusual 
ability to remain highly motile in mucus and it is thought that adhesion to host cells is 
not always necessary as the bacterium is able to remain in the intestine by colonising 
the mucus layer overlying the epithelium. Some studies have shown that the flagellum 
may contain adhesins for epithelial cells (McSweegan and Walker 1986; Walker et al. 
1986; Wallis 1994), but other experiments have shown that the flagellum does not 
seem to have a role in the adhesion in C. jejuni and C. coli (Ketley 1995). Production 
of fimbriae has not been observed (Walker et al. 1986), but various outer-membrane 
proteins and LPS (McSweegan and Walker 1986) have been described that bind to 
eucaryotic cells. These molecules have not been characterised yet as to their role in 
virulence (Ketley 1995). 
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1.5.1.2 Cytotoxins. 
After colonisation of the mucus, campylobacters disrupt the normal absorptive 
capacity of the intestine by damaging epithelial cells either by cell invasion, the 
production of toxin(s), or both (Wallis 1994). The occasional bacteraemia case 
(Ladr6n de Guevara et al. 1994) and inflammation of the intestine strongly suggest 
that cell invasion is an important pathogenic mechanism. Toxins may contribute to the 
disease process. Campylobacters have been reported to produce various toxic 
activities, including a cholera-like toxin (CJT) and several cytotoxins (Walker et al. 
1986; Suzuki et al. 1994), including a cytolethal distending toxin (CLDT), a shiga-like 
toxin (SLT) and a haemolysin (Wallis 1994; Ketley 1995). However, other studies 
have refuted the significance of these findings (Konkel et al. 1992). Many reports 
have also suggested that actin polymerisation is required for Campylobacter invasion 
because drugs that inhibit actin polymerisation also inhibit invasion (Wooldridge and 
Ketley 1997). However other studies report an absence of polymerised actin in 
association with sites of bacterial attachment (cited in Wooldridge and Ketley 1997). 
1.5.1.3 LPS. 
LPS is a virulence determinant in many species of Gram-negative bacteria. It has been 
shown to contribute to several areas of the pathogenic process including serum 
resistance, resistance to phagocytic killing, and cell toxicity (Ketley 1995; Rietschel 
and Brade 1992; Nikaido and Vaara 1985). Much progress has been made on the 
biochemical characterisation of C. jejuni LPS and most of the attention has been 
directed towards the utilisation of LPS in serotyping (Moran et al. 1991; Mills et al. 
1992a). C.jejuni LPS consists ofa low molecular weight fraction and in some cases it 
may also contain a high molecular weight fraction (preston and Penner 1989; Mills et 
al. 1992b; Aspinall et al. 1992). McSweegan and Walker detailed the role ofLPS as 
an important adhesin with results that indicate that the short 0 side chains of C. jejuni 
LPS molecules are involved in adhesion to INT 407 epithelial cells and mucus 
(McSweegan and Walker 1986). LPS was extracted from radiolabelled C. jejuni HC 
and used in a INT 407 cell adhesion assay. Tritiated LPS specifically bound to cells, 
verifying the role of LPS in attachment to epithelial cells. Periodate oxidation of the 
LPS reduced the binding of LPS to cells which suggests that binding of the LPS is 
through the carbohydrate portion of the LPS molecule (McSweegan and Walker 
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1986). LPS extracted from C. jejuni HC was also effective in blocking the attachment 
of whole C. jejuni HC cells to epithelial cells. 
C.jejuni is unusual in that many strains, eg., HS1, HS2, HS4, HS19, HS23, and HS36, 
do not display LPS with an extensive 0 side chain (Aspinall et al. 1994a; Yuki et al. 
1994). The presence of a rough LPS phenotype in C. jejuni may be a significant factor 
in its ability to colonise the epithelium, unlike strains with a smooth LPS phenotype 
(McSweegan and Walker 1986). The epithelial cell surface of the intestine appears to 
be the preferred binding site of both the flagellum and LPS, suggesting that the 
epithelial cell surface contains better Campylobacter receptors than does the intestinal 
mucus (McSweegan and Walker 1986). 
LPS is involved in the virulence of other Gram-negative pathogens and gives an 
intellectual basis for the search of such a role in C. jejuni. The role of the flagella in 
colonisation and invasion has been confirmed with defined genetic mutants (D. E. 
Taylor 1992), but similar studies have yet to be performed for the LPS from C. jejuni. 
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1.6 Overview of Lipopolysaccbarides. 
1.6.1 GENERAL INTRODUCTION. 
With the major exception of mycoplasmas, bacteria produce cell walls. In both Gram-
positive and Gram-negative bacteria the distinctive heteropolymer known as 
peptidoglycan is the component which contributes to the mechanical rigidity of the cell 
wall. All Gram-negative bacteria contain an additional layer in the cell wall structure, 
termed the outer membrane, which is located on the environmental side of the 
peptidoglycan layer (Nikaido and Vaara 1985; Stanier et al. 1984). The outer 
membrane is important in protecting Gram-negative bacteria from certain 
environmental and host-parasite interactions. Components of the outer membrane of 
the Gram-negative bacterial cell wall include phospholipids, LPS, proteins including 
the porins, the OmpA protein and a few enzymes including phospholipase At and 
proteases(s) (Stanier et al. 1984; Nikaido and Vaara 1985). The outer membrane is 
very important in the physiology of Gram-negative bacteria as it provides resistance to 
host defence factors such as lysozyme, B-Iysin, and various leukocyte proteins which 
are highly toxic to Gram-positive bacteria. Resistance to these elements correlates 
well with the presence of unusual structural components, LPS and porins (Nikaido and 
Vaara 1985). The outer membrane is a very effective barrier, providing protection to 
cells from the detergent action of bile salts and degradation by digestive enzymes 
found in intestinal tracts of animals (Nikaido and Vaara 1985). The outer membrane 
of some Gram-negative bacteria is able to act as·a strong permeability barrier to many 
antibiotics that are effective against other bacteria (Tamaki et al. 1971; Rietschel and 
Brade 1992). Another important function of the outer membrane is to endow the 
bacterial surface with strong hydrophilicity which is important in evading phagocytosis, 
complement resistance, and the capacity to avoid a specific immune attack by altering 
the surface antigen constitution (Nikaido and Vaara 1985; Schnaitman and Klena 
1993). Most work on the LPS has centred on the enteric bacteria E. coli and 
Salmonella typhimurium due to the well-established genetic systems available in these 
organisms. The remainder of this chapter is a basic overview of LPS, mainly derived 
from E. coli and S. typhimurium, as these two organisms are the models which most 
other studies on LPS have been based. 
Chapter I Introduction 14 
1.6.2 PATHOLOGY AND VIRULENCE. 
LPS is the major component of the outer membrane of Gram-negative bacteria (Wang 
and Reeves 1994; MacLachlan et al. 1991) accounting for 3-8% of the dry weight of 
the cell (Hancock et al. 1994). LPS is an immunodominant antigen for most Gram-
negative bacteria and is the essential component of bacterial endotoxins (Schnaitman 
and Klena 1993). Since their discovery in the late 1800's, bacterial endotoxins have 
been among the most widely studied of all bacterial components, due, in large part to 
the diversity of biological responses which this molecule elicits both in vitro and in 
vivo (Hitchcock et al. 1986). Endotoxins can elicit disease symptoms ranging from 
chills and fever to irreversible shock (circulatory failure leading to malfunctioning of 
organs throughout the body), and death. Paradoxically, these same endotoxins can 
enhance the body's overall immune resistance to bacterial and viral infections and 
cancer (Rietschel and Brade 1992)' The realisation that endotoxins have a unique 
structure to which immunological and biological properties appeared to be related led 
to considerable research being carried out in the 1950's and 1960's on LPS structure. 
Most of the studies focused on enteric bacteria including various members of the 
Salmonella and Escherichia genera, especially E. coli. As a result of this research 
there is now a near thorough characterisation of the biosynthesis, immunochemistry, 
chemical composition, genetic regulation and structure of LPS species produced by 
various isolates of Salmonella and E. coli. 
1.6.3 HETEROGENEITY OF LPS. 
Microorganisms exposed to the selective pressure of an immune system need to 
generate and maintain cell surface diversity for their survival, often within extremely 
diverse and inhospitable habitats. LPS chemical heterogeneity may be important at the 
species or subspecies level to generate diversity for survival. Through genetic 
variation it is possible that LPS may vary within a single isolate. Mills et al. (1992b) 
have reported a shift in the antigenic spectrum of C. jejuni within one host, and in 
Neisseria gonorrhoeae it has been shown that not only can lipooligosaccharide (LOS) 
structure vary between strains, but that each strain is also able to produce an 
assortment of LOS, depending on the environment that the organism is exposed to 
(Schneider et al. 1984; Kerwood et al. 1992). 
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The LPS molecule is generally conserved in its overall structure. It consists of three 
main regions: a lipid A region, a non-repeating core oligosaccharide region and a 
polymeric 0 antigen (Stanier et al. 1984; Wang and Reeves 1994; Crowell et al. 1986) 
(Figure 1). The molecular weight of individual LPS molecules can vary from about 
3,000-54,000 Da according to the lack of or presence of variable numbers of the 
repeating saccharide units that comprise the 0 antigenic polysaccharide. However, 
certain bacterial species, including Neisseria spp., Haemophilus injluenzae and 
Bordetella pertussis, do not produce 0 antigen containing polysaccharides. Instead 
the carbohydrate portion attached to lipid A consists of approximately 10 
monosaccharides and these molecules are termed lipooligosaccharides (also called R-
type or rough LPS) (Hancock et al. 1994). 
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Figure 1. Schematic representation of the membrane lipids and proteins in the Escherichia coli 
envelope. Glycerophospholipids are depicted showing fatty acyl chains (as zig zags) with a polar 
head group sphere attached; sugar residues are drawn as ovals or short lines. The proteins of the 
inner and outer membranes are unique, and there are 50-100 distinct proteins in each membrane. The 
membrane-derived oligosaccharides (MDOs) are found in the periplasm. The minimal 
lipopolysaccharide required for growth of E. coli consists of the lipid A domain and two 
phosphorylated 2-keto-3-deoxyoctulosonic acid (KDO) residues (Adapted from Raetz 1986). 
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1. 7 LPS and Cellular Viability. 
In enteric and non-enteric bacteria the innermost region of the LPS appears to be 
essential to bacterial survival. This region consists of lipid A, and at least two residues 
of 2-keto-3-deoXY-D-manno-octulosonic acid (KDO) from the core (Raetz 1986). 
This next section presents an overview of the different regions ofLPS. 
1.7.1 LIPID A. 
Lipid A is a non-conventional hydrophobic phospholipid. Eubacterial phospholipids 
are glycerol esters, however lipid A is composed of two molecules of N-
acetylglucosamine (GlcNAc) containing 3'-hydroxy linked fatty acids (FAs) which 
helps to anchor the LPS in the outer membrane. In E. coli and Salmonella spp. this 
structure is relatively conserved with regard to both F As and GlcNAc composition 
(Raetz 1986). 
Variation may exist III the length of FA branches and/or non-stoichiometric 
substituents located on the GlcNAc residues. Non-enteric bacteria that grow at lower 
temperatures (for example, N gonorrhoeae and Pseudomonas aeruginosa), possess 
lipid A molecules with somewhat shorter fatty acyl chains. This alteration might 
function to optimise the physical properties of lipid A for growth at lower 
temperatures (Takayama et al. 1986; Raetz 1990). Gram-negative bacteria such as P. 
aeruginosa may differ in the FA composition of their lipid A, sometimes containing S-
2-hydroxy F As in acyl oxyacyl linkage as opposed to R-3-hydroxy F As that are 
attached to the glucosamine backbone (Raetz 1990). 
1.7.2 NON-REPEATING LPS CORE. 
The core is a hydrophilic non-repeating oligosaccharide consisting of an inner and 
outer region. The core oligosaccharide is composed of a variety of sugars, including 
certain unique species that are characteristic of LPS, such as KDO and L-glycero-D-
manno-heptose (Rep) (Reeves 1994). The eight-carbon sugar KDO, is linked u2,6' to 
the lipid A disaccharide. This attachment is catalysed by the enzyme KDO transferase, 
which is encoded by the kdtA gene in E. coli (Belunis et al. 1995). In E. coli, strains 
that are defective in lipid A or KDO biosynthesis have only been isolated as conditional 
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lethal mutants. KDO has not been found in mammalian cells. Mutants unable to 
produce KDO are non-viable and thus this sugar is a promising target in the design of 
novel antibacterial agents (Hammond et al. 1987). Two synthetic antimicrobial agents 
have been designed which specifically target CMP-KDO synthetase, encoded by the 
gene kdsB. These agents inhibit LPS synthesis and cause accumulation of lipid A 
precursors, resulting in growth stasis and eventually, bacterial death (Goldman et al. 
1987; Hammond et al. 1987). These agents directed against KDO metabolism ought 
to be endowed with a high degree of selective toxicity (Hammond et al. 1987). 
Other core sugars include glucose, galactose and GlcNAc (Raetz 1990). The core 
region is relatively conserved among related Gram-negative bacteria (Raetz 1986), 
especially the inner core region (Rietschel and Brade 1992). Because this innermost 
region is more conserved than the 0 antigen in Gram-negative organisms, it is a major 
target for generation of antibodies and therapeutic agents as a means to antagonise 
Gram-negative sepsis (Dasgupta et al. 1994). Various monoclonal antibodies directed 
against the LPS core have been reported, and some researchers have demonstrated that 
core-lipid A-specific monoclonal antibodies can confer protection against experimental 
Gram-negative sepsis (Dasgupta et al. 1994). 
The exact structures of lipid A and the inner-core region of completed LPS molecules 
are still not known in E. coli K-12 or S. typhimurium. Non-stoichiometric 
modifications which are best characterised include a 4-aminoarabinose attached to the 
I-phosphate of lipid A and a phosphoryl-ethanolamine (PEA) substituent attached to 
the 7 position ofKDO (Raetz 1990; Schnaitman and Klena 1993). 
1.7.3 0 ANTIGEN. 
The 0 antigen is a hydrophilic polymer composed of from one to five carbohydrates, 
commonly including hexoses, amino-hexoses, dideoxyhexoses and methylpentoses 
(Reeves 1994). These sugars are often found in repeating tetra- or pentasaccharide 
units, although monosaccharides exist as well. The 0 antigen occurs as a side chain 
attached to the non-reducing end of the LPS core (Schnaitman and Klena 1993); ie. it 
is present at the cell surface. Genetic studies using bacteriophages have demonstrated 
that bacterial cells unable to produce an 0 antigen are viable and only have a slightly 
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reduced growth rate when compared to wild-type strains (Raetz 1986). However, 
rough variants of smooth strains are often avirulent (LPS of bacteria containing 0 
antigens are denoted as smooth (S), and those which lack 0 antigens are denoted as 
rough (R) (Hitchcock et al. 1986). The 0 specific chain is the most variable segment 
of LPS when compared among genera, species and subspecies of bacteria (Rietschel 
and Brade 1992). Alterations of the 0 antigen (for example, phage conversion in 
Salmonella) change the properties of the LPS, in some cases by altering bacterial 
surface charge or by masking or unmasking surface exposed proteins. The 0 antigen 
is generally the heat-stable molecule used in serotyping - agam exploiting this 
variability (Raetz 1990; Schnaitman and Klena 1993). 
1.8 Lipid A. 
In the next section, I will describe key features of the biochemistry and genetics of lipid 
A biosynthesis in E. coli. I will describe features of lipid A biosynthesis in other 
organisms when it has been described. 
1.8.1 SIGNIFICANCE OF LIPID A AND ITS PRECURSORS: 
The lipid A moiety is responsible for most of the biological activities and toxic 
properties associated with LPS. Mature lipid A (ie. lipid A with KDO disaccharide 
attached) is a potent toxin capable of inducing a severe shock syndrome in humans and 
other large mammals. Lipid A and many of its precursors stimulate proliferation of /3-
lymphocytes and these molecules activate macrophages, an event that is accompanied 
by prostaglandin release (Hampton et al. 1991). Monosaccharide precursors of lipid A 
(for example lipid A precursors that contain only a single GlcNAc residue) are 
nontoxic, but retain some of the "beneficial" immunostimulatory effects. The 
precursor lipid X (see section 1.8.2.1) has been shown to desensitize animals, such as 
mice and sheep, against the lethal toxicity of purified mature lipid A alone or LPS 
(Raetz 1986). This finding may have important clinical applications (Raetz 1986). In 
another study it was found by enzyme-linked immunosorbent assay (ELISA) that 
lactoferrin binds directly to the isolated lipid A portion of intact LPS of clinically 
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relevant bacteria. This event may result in bacterial growth reduction and/or killing, as 
well as in decreased endotoxicity of LPS occurring both in the bloodstream and at 
mucosal surfaces. Further studies of LPS as an anti-endotoxin agent are therefore 
warranted (Appelmelk et al. 1994). 
1.8.2 LIPID A SYNTHESIS IN E. coli AND S. typhimurium. 
The predominant species of lipid A in E. coli and S. typhimurium (Figure 2) is a f3(l-
6)-linked disaccharide composed of two N-acetylglucosamine (GlcNAc) residues, with 
R-3-hydroxymyristoyl substitutions at positions 2, 3, 2' and 3', and phosphate 
substitutions at positions 1 and 4' (Galloway and Raetz 1990~ Anderson and Raetz 
1987). Attached at position 6' of the non-repeating GlcNAc through an a. glycosidic 
linkage are two KDO molecules. All other sugars (if present) are attached to the LPS 
at these KDO moieties (Anderson and Raetz 1987) (Figure 3). 
Q-Antigen 
Lipid A 
Figure 2. Structure of E. coli and S. Iyphimurium lipid A. Positions 1 and 4' may be substituted by 
either phosphate, phosphatidylglycerol or 4-aminoarabinose at non-stoichiometric levels (Adapted 
from Raetz 1990). 
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Figure 3. Carbohydrates that compose lipid A and inner core regions of enteric bacteria and the 
genes involved in their synthesis. The lipid A -inner core region is a composite of E. coli K-12 and S. 
typhimurium structures. Partial substituents are indicated by dashed lines. The abbreviations BHM, 
FAl2, and FA14 represent P-hydroxymyristate, laurate, and myristate substituents respectively; P 
represents phosphate. GleN represents glucosamine; PEA a phosphorylethanolamine, and PPEA a 
pyrophosphorylethanolamine; AraN 4-aminoarabinose (Adapted from Schnaitman and Klena 1993). 
I.S.2.1 Overview of Synthesis. 
UDP-GlcNAc is an important intermediate in cell surface biosynthesis and is situated at 
a biosynthetic branchpoint in E. coli leading either to peptidoglycan or lipid A 
synthesis (Figure 4). R-3-hydroxymyristoyl-acyl carrier protein (ACP), the other 
unique early precursor of lipid A, is also a common intermediate since it is able to be 
incorporated into both lipid A and glycerol-based phospholipids (Schnaitman and 
Klena 1993). It comes as no surprise that the elucidation of the biosynthetic pathway 
of lipid A was discovered during a search for genes involved in early steps of 
glycerophospholipid synthesis (Raetz 1986). Raetz and co-workers found that certain 
phosphatidylglycerol-deficient mutants of E. coli accumulate monosaccharide 
precursors of lipid A. This led to the discovery of a lipid with the structure 2,3-
diacylglucosamine-1-phosphate. This lipid was given the name lipid X and the 
structure suggested that it might be a biosynthetic precursor of the reducing end unit of 
mature lipid A. Raetz and co-workers were led to postulate a biosynthetic role for 
lipid A (Anderson et al. 1985) (Figure 5). 
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Figure 4. Biosynthesis and partitioning of UDP-GlcNAc in E. coli. UDP-GlcNAc is situated at a 
branchpoint in E. coli leading to either lipid A or peptidoglycan (for details see text). Abbreviations: 
GleN, glucosamine; acetyl CoA, acetyl coenzyme A; ACP, acyl carrier protein; PEP, 
phosphoenolpyruvate; NAM, N-acetylmuramic acid; LPS, lipopolysaccharide (Adapted from Raetz 
1987). 
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Figure 5. Postulated scheme for the biosynthesis of lipid A in E. coli. In the figure, R designates a /3-
hydroxymyristoyl moiety and U designates uridine (Adapted from Ray and Raetz 1987). 
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1.8.2.2 Role of IpxA. 
The first step of lipid A biosynthesis in E. coli and S. typhimurium involves the transfer 
of a FA, R-3-hydroxymyristic acid, from an acyl carrier protein (ACP) to the 3-0H 
group of the glucosamine ring ofUDP-G1cNAc (Coleman and Raetz 1988). UDP-N-
acetylglucosamine (UDP-GlcNAc) acyltransferase is encoded by the lpxA gene, which 
has been cloned- and sequenced in E. coli (Coleman and Raetz 1988) and maps to the 
minute 4 region of the E. coli K-12 map (Galloway and Raetz 1990). The 
acyltransferase gene was discovered by the isolation of a tight (ie. not easily revertable) 
conditional lpxA mutant in which UDP-N-acetylglucosamine acyltransferase activity 
was absent in cell extracts. This strain is temperature-sensitive (ts) for growth. 
Characterisation of this mutation provided the evidence that UDP-G1cNAc 
acyltransferase catalyses the initial step for lipid A biosynthesis in E. coli and that lipid 
A is an essential molecule (Galloway and Raetz 1990). The (ts) phenotype can be 
corrected by lpxA + -bearing plasmids which overproduce the UDP-G1cNAc 
acyltransferase enzyme (Raetz 1987). 
The lpxA gene is part of a cluster of 11 genes organised into an operon called the 
macromolecular synthesis II operon (see below) (Schnaitman and Klena 1993). The 
amino acid sequence from lpxA reveals similarity to LpxD, the enzyme catalysing the 
third step of LPS biosynthesis, and also to several unrelated bacterial acetyl 
transferases. The regions of similarity in common to all of these proteins include a 
repeating sequence motif which has been termed a "hexapeptide repeat" or an 
"isoleucine patch" (Vuorio et al. 1991~ Vuorio et al. 1994) (see section 1.8.2.3). 
1.8.2.3 Lipid X Formation. 
Step two in the lipid A pathway involves N-deacetylation of the O-acylated UDP-
GlcNAc, catalysed by the enzyme UDP-3-0-(R-3-hydroxymyristoyl)-acyl-
acetylglucosamine deacetylase (envA/lpxC gene product). Step three in the pathway 
involves the transfer of a second acyl group from R-3-hydroxymyristoyl-ACP to the 
amino group to form UDP-2,3-diacylglucosamine (as a result of LpxD) which is the 
precursor of the nonreducing end of lipid A (Dicker and Seetharam 1992). In step 
four, two hydrolases (one a CDP-diglyceride hydrolase and one as yet uncharacterised) 
cleave UDP-2,3-diacylglucosamine to generate lipid X and uridine-monophosphate 
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(UMP) (Bulawa and Raetz 1984a). Anderson et al. carried out short-term labelling of 
E. coli with 32Pi to reveal that the precursor oflipid X was UDP-2,3-diacylglucosamine 
(Anderson et al. 1985). 
The LpxD protein from E. coli and S. typhimurium shares an unusual regIon of 
homology termed an 'isoleucine patch' or 'the acetyltransferase motif with LpxA, 
LacA, CysE, DapD of E. coli, NodL from Rhizobium leguminosarum, the three 
hypothetical proteins Y glm of E. coli, its analogue Tms of Bacillus subtilis as well as 
Yerm of B. sphaericus, and FirA and LpxA from Rickettsia rickettsU. LpxA, LacA, 
CysE, NodL and LpxD are all acyltransferases (Vuorio et al. 1991; Vaara 1992; Shaw 
and Wood 1994; Vuorio et al. 1994; Vuorio and Vaara 1995). Periodicity repeat 
themes are very rare in enzymes. It is plausible to expect that the hexad regions of 
LpxA and LpxD form a structural (non-catalytic) part of the protein. The crystal 
structure for LpxA in E. coli has been determined and from the structure the roles of 
the conserved residues of the hexapeptide repeat sequence motif have been identified 
(Raetz and Roderick 1995). The secondary structure is composed of an NHrterminal 
domain of predominantly parallel p-sheet structure and a COOH-terrninal domain 
containing four a. helices. The predominance of p-structure is found in the conserved 
hexapeptide region. Thus, the repeating hexapeptide pattern observed in IpxA is 
important is secondary structure folding allowing formation of a well-packed and 
nearly symmetric hydrophobic core (Raetz and Roderick 1995). 
R. rickettsii 
firA H ORF16 lexA 
35% 44% 41% 
flrA H ORF17 I lexA 
~rA hlpA ORF17 le.xA I le.xB ORF23 dnaE ORF37 
c:=J--t H I I I I 
E. coli dnaE Region 
Figure 6. Spacing of the Rickettsia rickettsi; and Escherichia coli jirA-lpxA region of genes. This 
schematic demonstrates the relative size and spacing of the R. rickettsii genes with respect to the 
analogous E. coli dnaE region. Boxes represent the coding sequences and lines represent the 
nucleotides separating them with sizes drawn to scale. The percentages indicate the percent of 
identical amino acids between E. coli and R. ricketts;; proteins. orJll is now known to be JabZ 
(Adapted from Shaw and Wood 1994). 
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1.8.2.4 Lipid IV A Assembly. 
The fifth step in the biosynthesis of lipid A (figure 5) is catalysed by the protein 
product of the lpxB gene, lipid A disaccharide synthase (Raetz 1986). Disaccharide 
synthase (lpxB gene product) condenses a molecule of 2,3-diacyl-GlcN-1-P (lipid X) 
with a molecule of UDP-2,3-diacylglucosamine to give tetraacyldisaccharide-1-
phosphate. The disaccharide synthase cannot condense two molecules of UDP-2,3-
diacylglucosamine directly. Tetraacyldisaccharide-1-phosphate is phosphorylated in E. 
coli at position 4' yielding the tetraacyldisaccharide-1, 4' -bisphosphate (lipid IVA). 
Mutations in lpxB are interesting and non-lethal and provide further evidence for the 
lipid A biosynthetic scheme. lpxBJ causes a 100-fold reduction in the specific activity 
of the lipid A disaccharide synthase (Ray et al. 1984). High levels of 2,3-
diacylglucosamine-1-phosphate (lipid X) and UDP-2,3-diacylglucosamine accumulate 
in cells containing the lpxBJ mutation (Bulawa and Raetz 1984b). Mutants defective 
in the lpxB gene are still capable of generating mature lipid A. It is thought that the 
accumulation of the precursor molecules compensates for the reduction in the level of 
disaccharide synthase (Raetz 1986). 
lpxB (pgsB) has been sequenced in E. coli and is adjacent to lpxA within the operon 
(Coleman and Raetz 1988). lpxA and lpxB have been shown to be transcribed in a 
clockwise direction and it is thought that these two genes are cotranscribed (Crowell et 
al. 1986). The biological significance of the lpx operon is not yet certain, but it may be 
of importance in the control of E. coli envelope assembly (Raetz 1987). The lpxA and 
lpxB genes map in close proximity to dnaE, the gene encoding the a. subunit of DNA 
polymerase III (Tomasiewicz and McHenry 1987). Other genes located in this region 
include IpxD (!irA), and orfl7 (jabZ) (Mohan et al. 1994). The product of the lpxD 
gene is involved in step 3 of lipid A biosynthesis (figure 5). At least two other genes 
are part of this complex operon. One, located downstream of lpxB, is an open reading 
frame coding for a 23-kilodalton (kDa) polypeptide, and the other is another open 
reading frame, downstream of dnaE, able to code for a 37-kDa protein (Figure 7). 
To date, work on lipid A biosynthesis has primarily been carried out only with E. coli, 
but the structure of lipid A from Salmonella typhimurium and S. minnesota is virtually 
the same as that of E. coli (Ray et al. 1984; Bulawa and Raetz 1984a; Anderson et al. 
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1985). Although several notable structural differences exist between the lipid A of E. 
coli and Rhizobium leguminosarum, a study by Price et al. (1994) concluded that the 
early steps in lipid A biosynthesis are conserved and that divergence leading to 
rhizobiallipid A may occur at a later stage in the pathway, presumably after attachment 
of the KDO residues (price et al. 1994). 
All of the enzymes in the lipid A biosynthetic scheme through to the disaccharide 
synthase are recovered in the cytoplasmic cellular fraction (Anderson et al. 1985). 
However it is thought that these early enzymes of lipid A biosynthesis function as 
peripheral membrane proteins on the inner surface of the inner membrane, due to the 
fact that lipid X is membrane bound (Raetz 1987). In E. coli the first integral 
membrane protein in the lipid A pathway is the 4' kinase in the sixth step of the 
pathway. This was determined by fast atom bombardment (F AB) mass spectrometry 
and by IH and 31p_NMR spectroscopy (Ray and Raetz 1987). The first five substrates 
in lipid A biosynthesis have been shown to occur in cell extracts, and the structures of 
the metabolites have been verified by nuclear magnetic resonance (NMR) 
spectroscopy, mass spectrometry, and chemical analysis (Raetz 1986). 
1.S.2.5 "Lipid IV A-KDO: Minimal Unit for Viability". 
Lipid IVA is the minimal substrate to which KDO residues are attached. The 
tetraacyldisaccharide-1,4' -bisphosphate intermediate is of considerable interest, not 
only as a precursor in the pathway to mature lipid A, but also because it possesses 
many of the biological activities of lipid A and LPS, especially the immunostimulatory 
properties (Raetz et al. 1985; Raetz 1987). 
Attachment of the KDO residues and the "piggy-backed" fatty acids (3-hydroxy-acyl 
fatty acids) to the nonreducing end of lipid A is less well characterised. The gene that 
codes for the bifunctional KDO transferase has been cloned (kdIA). It maps near 
minute 81 between ria and pyrE (Clementz and Raetz 1988, cited from Raetz 1990). 
This transferase transfers two KDO residues from two CMP-KDO molecules to lipid 
IVA, termed (KDO)rIV A. Brozek and Raetz have demonstrated the presence of 
enzymes in E. coli extracts that transfer laurate and/or myristate residues from lauroyl 
or myristoyl-acyl carrier protein (ACP) to (KDO)rIV A. These acyltransferases are 
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unable to utilise lipid IVA alone as a substrate, showing that they possess novel KDO 
recognition domains (Brozek and Raetz 1990). 
Temperature-sensitive mutants of S. typhimurium that are deficient in KDO 
biosynthesis accumulate disaccharide precursor(s) of lipid A under non-permissive 
conditions (Raetz et al. 1985). The conditional lethality of KDO-deficient mutants 
may be due to the absence of mature lipid A or due to the accumulation of the 
disaccharide precursors in the inner membrane (Raetz 1986). 
1.9 C. jejuni LPS. 
1.9.1 OVERVIEW. 
The LPS of C. jejuni is biologically active in humans, results in endotoxic shock and 
has been identified in mediating attachment of the bacterium to epithelial cells, acting 
as an adhesin (McSweegan and Walker 1986). 
Biochemical characterisation of the C. jejuni LPS has revealed the presence of typical 
components such as D-glucose, D-galactose, phosphate, KDO, Hep, D-glucuronic acid, 
glucosamine (GleN), D-galactosamine, ethanolamine, ethanolamine-phosphate, and 
fatty acids (Conrad and Galanos 1990~ Moran et al. 1991a~ Moran et al. 1991b). 
However these fatty acids are shorter than those seen in E. coli. Fatty acids reported 
in four C. jejuni strains were tetradecanoic acid, hexadecanoic acid, and 3-
hydroxytetradecanoic acid (Moran 1995). In addition, more variety in the core region 
has been noted amongst C. jejuni isolates than with other bacterial species (Moran 
1995). 
D-mannose is reported to be present in the LPS of C. jejuni biotype 2 but absent in that 
of the more common C. jejuni biotype 1 (Moran et al. 1991a). N-acetyl neuraminic 
acid (Neu5Ac) as well as KDO was found in the LPS of three strains of C. jejuni. 
Presence ofNeu5Ac was unexpected~ Neu5Ac is found only rarely in procaryotes but, 
when it is present, it usually occurs as a component of capsular polysaccharide (cited 
from Moran et al. 1991a). Neu5Ac is chemically related to KDO but uncommon in 
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LPS. Neu5A is a chainlinked polymer when present in capsular polysaccharide and 
confers on the capsular polysaccharide low or no immunogenicity because of structural 
mimicry to mammalian host components (Moran et al. 1991a). It is unknown whether 
the presence ofNeu5Ac in C. jejuni LPS contributes to serum resistance as it does in 
Rhodobacter spp. 
Electrophoretic analyses indicate that wild-type strains of C. jejuni produce S 
(smooth)-form LPS, structurally distinct low molecular weight LPS containing 
sialylated oligo saccharides, or both (Moran 1995). The low molecular weight LOS 
type is similar to that found in pathogens such as Neisseria, Haemophilus and 
Bordetella spp. (Walker et al. 1986) showing that there is a variety of corelLPS 
structures in different bacteria. 
1.9.2 LIPID A OF C. jejuni. 
The lipid A component of C. jejuni LPS also has unusual chemical properties in 
comparison with that of E. coli and Salmonella spp. As mentioned before, E. coli and 
Salmonella spp. have a rather conserved lipid A structure characterised by a ~(1-6)­
linked D-glucosamine (GleN) disaccharide backbone with attachments of phosphate 
groups and fatty acids. LPS analysed from bacteria having diverse origins, using 
techniques like high voltage paper electrophoresis (HYPE), serological studies, 
chemical studies and structural studies, has shown the occurrence of structurally 
deviating lipid A molecules with monosaccharide or disaccharide backbones composed 
of other amino acids such as 2,3-diamino-2,3-dideoxy-D-glucose (GlcN3N) or 
glucosaminuronic acid (Weckesser and Mayer 1988). In C. jejuni lipid A may contain 
both GlcN and GlcN3N (Moran et al. 1991a). Previous work by Moran and 
coworkers has shown that C. jejuni CCUG 10936 (serotype HS2) LPS contains three 
lipid A backbones composed of GlcN-GleN, GlcN3N-GlcN3N, and a hybrid 
disaccharide GlcN3N-GlcN in the ratio 1: 1.2:6 respectively (Moran et al. 1991b). 
Techniques showing the breakdown of the LPS into the separate lipid A portions 
included chromatographic techniques such as HVPE, thin-layer chromatography 
(TLC), gas-liquid chromatography/mass spectrometry (GLC-MS), laser desorption 
mass spectrometry (LDMS), and 31p_NMR spectroscopy, as well as chemical 
degradation procedures (Moran et al. 1991b). This study also showed that C. jejuni 
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LPS purified usmg the hot phenol-water technique, possesses 50% lower lethal 
toxicity, 30- to 50-fold lower pyrogenicity and a 100-fold lower ability to induce 
tumour necrosis factor (TNF) secretion than Salmonella spp. LPS (Moran 1995). 
As C jejuni lipid A differs in its backbone composition, and possesses acyl chains of 
different lengths (Moran et al. 1991a; Moran et al. 1991b), it is thought that these 
structural differences might account for the lower biological activities of C jejuni LPS 
compared with Salmonella LPS (Moran 1995). The presence of both D-glucosamine 
and 2,3-diamino-2,3-dideoXY-D-glucose in C jejuni lipid A is a novel finding as it was 
thought that only D-glucosamine was the major amino sugar component in the lipid A 
ofCjejuni (Moran et al. 1991b). 
1.10 Objectives of this study. 
Most Gram-negative bacterial LPS contains a lipid A-like substance. Even diverse 
phototrophic bacteria, assumed to have emerged relatively early in evolution, contain 
lipid A (Weckesser and Mayer 1988). Lipid A biosynthesis in C jejuni appears to 
involve novel pathways with unique intermediates. Given the conservation of the lipid 
A pathway in E. coli and other related Gram-negative bacteria it is relevant to 
investigate the biosynthesis of lipid A in C. jejuni. Work on the organisation and 
regulation of LPS biosynthetic genes in this organism may help in deducing the role 
LPS plays in virulence relationships. There is also interest in identifYing C. jejuni 
genes and proteins in the LPS which may be useful in the development of diagnostic 
assays or vaccine formulations. A nontoxic, effective vaccine would be desirable in 
both developed and developing countries as C jejuni infection is widespread and 
economically expensive, in terms of lost production time, sick-day pay and many other 
reasons (Konkel et al. 1996). 
UDP-N-acetylglucosamine acyltransferase is encoded by the lpxA gene. The lpxA gene 
product is essential for the production of LPS in E. coli as null mutations in lpxA are 
lethal. The initial aim of this study was to characterise the lpxA gene hypothesised to 
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be necessary for synthesis of at least one type of lipid A in C. jejuni. It was proposed 
that C. jejuni contains an enzyme that is functionally analogous to LpxA from E. coli. 
Genetic manipulations were originally performed in E. coli as the genetics of this 
system is well characterised. C. jejuni is not a well characterised genetic system and 
identification of putative LpxA analogs was facilitated by interspecies complementation 
analysis in E. coli. This was achieved by tracnsformation of a genomic plasmid 
expression library containing C. jejuni DNA into the strain E. coli KLC 4177 (lpxA} 
1.10.1 AIMS: 
• To determine whether C. jejuni has an lpxA-like gene; 
• To sequence the lpxA gene in C. jejuni; 
• To characterise the uniqueness of the lpxA gene in the C. jejuni chromosome; 
• To identify the lpxA gene product, UDP-N-acetylglucosamine acyltransferase, from 
C. jejuni and assess its ability to restore growth in interspecies complementation 
analyses; and as time permitted, 
• To attempt to create a 'null mutation' in the lpxA gene of C. jejuni using a Kmr 
cassette by homologous recombination and assess function ofLpxA protein. 
These aims were carried out to determine if C. jejuni has a conserved lipid A 
biosynthetic pathway as shown in many other Gram-negative bacteria, not just the 
enterics. An E. coli temperature-sensitive mutant defective in LpxA activity provides a 
system with which to study the effect of acyltransferase deficiency on cell viability. 
Temperature-complementation of the lpxA defect within this mutant E. coli strain 
enables identification of an lpxA -like gene from C. jejuni. By sequencing the lpxA 
gene from C. jejuni it will be shown whether the sequence differs from that in E. coli 
as suspected, and whether the predicted LpxA protein from C. jejuni shows the 
conserved isoleucine patches as in other bacteria. Sequencing will also play a large 
role in constructing a 'knockout' mutation within the C. jejuni chromosome if time 
permits. 
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CHAPTER II. 
MATERIALS AND METHODS. 
2.1 BACTERIAL STRAINS AND PLASMIDS. 
The bacterial strains and plasmids that have been used in this study are listed in 
Table 2. 
Table 2. Bacterial strains and plasmids used. 
Strain Description of Relevant Genotype Source 
Escherichia coli 
KLC 4000 DRSa.; recAl Laboratory collection 
KLC 4176 SMI0S; F thr-l ara-14 tsx-78 E. coli Genetic Stock 
l1(galK-attA)99 hisG4(Oc) rfbDl Centre (EGSC) 
1psL136(st?') xylAS mtl-l thi-l 
KLC 4177 SMI0l; F thr-l ara-14 tsx-78 EGSC 
l1(galK-attA)99 hisG4(Oc) rfbDl 
rpsL136(st?') xylAS mtl-l thi-l 
ipxA2(ts) 
KLC 4178 KLC 4177/ /pCIl Apr This study 
KLC 4179 KLC 4177/ /pCI2 Apr This study 
KLC 4180 KLC 4177/ /pCI3 Apr This study 
KLC 4181 KLC 4177//pCI4 Apr This study 
KLC 4182 KLC 4177/ /pCIS Apr This study 
KLC 4183 P678-S4T; F- thr leu thi supE lacY H. K. Mahanty 
tonA gal mal xyl ara mtl min 
KLC 4184 KLC 4183//pCIl Apr This study 
KLC 4185 KLC 4183//pCI2 Apr This study 
KLC 4186 KLC 4183//pCI3 Apr This study 
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Table 2. Continued. 
Strain 
KLC 4187 
KLC 4188 
KLC 4189 
KLC 4190 
KLC 4199 
KLC 4200 
KLC 4201 
KLC 4203 
KLC 4204 
KLC 4205 
KLC 4026 
KLC 4027 
JM109 
Campylobacter jejuni 
KLC4132 
F38011 
Plasmids 
pBluescriptSKII+ 
pGE~-T 
Materials and Methods 
Description of Relevant Genotype 
KLC 4183//pCI4 Apr 
KLC 4183//pCI5 Apr 
KLC 4183//pBIISK(+) Apr 
KLC 4000//pCI6 Apr 
KLC 4000//pCI102 Apr 
KLC 4000//pCI103 Apr 
KLC 4000//pCI104 Apr 
KLC 4000//pCI112 Apr 
KLC 4000//pCI113 Apr 
KLC 4000//pCI114 Apr 
CSR 603 Maxicell parent strain. 
KLC 4026//pBIISK(+) Apr 
recA1 endA1 gyrA96 thi hsdR17 (rK-, 
mK+) relA1 supE44 11(lac-proAB) 
[F', traD36, proAB, lacIQZl1M15] 
NZRM 1958 (NCTC 11168) 
(Faeces, human enteritis) 
human gastroenteritis 
Apr, colE 1 ori 
Apr, colE1ori, PCR cloning vector 
32 
Source 
This study 
This study 
Laboratory collection 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Laboratory collection 
Laboratory collection 
Promega 
CDC, Wellington 
M. E. Konkel 
(Washington State 
University) 
Stratagene 
Promega 
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Table 2. Continued. 
Plasmid Description of Relevant Genotype Source 
pcn pBIISK(+)::1.5 kb 'jabZ-lpxA' This study 
fragment (c. jejuni F3 80 11) Apr 
pCl2 pBIISK(+)::300 bp 'jabZ-lpxA' This study 
fragment (c. jejuni F3 80 11) Apr 
pCB pBIISK(+)::450 bp 'jabZ-lpxA' This study 
fragment (c. jejuni F3 80 11) Apr 
pCl4 pBIISK(+)::2.7 kb 'jabZ-lpxA' This study 
fragment (c. jejuni F3 80 11) Apr 
pCl5 pBIISK(+)::2.5 kb 'jabZ-lpxA' This study 
fragment (c. jejuni F3 80 11) Apr 
pCl6 pGEM-T::'jabZ-lpxA' (C.jejuni This study 
NZRM 1958) Apr 
pCn02 pBIISK(+)::0.6 kb EcoRIlEcoRI This study 
fragment from pcn Apr 
pCn03 pBIISK(+)::0.7 kb EcoRIlEcoRI This study 
fragment from pcn Apr 
pCn04 pBIISK( +):: 1 kb EcoRIlEcoRI This study 
fragment from pCll Apr 
pCn12 pBIISK( +): : 1.1 kb HindIIII HindIII This study 
fragment from pcn Apr 
pCn13 pBIISK(+)::0.9 kb HindIIIIHindIII This study 
fragment from pcn Apr 
pCn14 pBIISK( +): :0.3 kb HindIIIIHindIII This study 
fragment from pcn Apr 
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2.2 BUFFERS AND MEDIA. 
Solutions and media used in this study were prepared as described in Appendices 1 and 
2. 
2.2.1 ANTIBIOTICS AND SUPPLEMENTS. 
Antibiotics and colourimetric reagents were added to liquid or solid media where 
necessary, to maintain selection pressure or to identify strains and constructs, in the 
concentrations shown in Table 3. 
Table 3. Antibiotics and supplements. 
Antibiotic 
ampicillin 
kanamycin 
cycloserine 
5-bromo-4-chloro-3-indoyl-
13-D-galactopyranoside 
Abbreviation 
Ap 
Km 
Cs 
X-gal 
2.3 BACTERIOLOGICAL METHODS. 
2.3.1 CULTURE CONDITIONS. 
Concentration 
50 mg/rnl 
30 mg/rnl 
50 mg/ml 
40 mg/rnl 
Escherichia coli strains KLC 4177 and KLC 4176 were incubated aerobically at 30°C 
on M9 minimal salts media (MM) including histidine (His) and threonine (Thr) + 1.5% 
agar unless otherwise stated. All other E. coli strains were grown aerobically at 37°C 
in Luria Broth (LB) or LB broth + 1.5% agar (LBA). All Campylobacter jejuni 
strains were grown in a reduced oxygen environment (10% CO2) at 42°C on Oxoid 
Campylobacter blood:-free selective agar base (Modified CCDA-Preston) containing 
the antibiotic cefoperazone (3.2g/L) or on Mueller-Hinton Media. C. jejuni was 
confirmed by Gram stain. 
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2.3.2 OVERNIGHT CULTURES. 
Single E. coli colonies were resuspended in 5 m1 LB broth containing antibiotics as 
required (see Table 2), with aeration (200 rpm) and incubated at the appropriate 
temperature for 16 hours before harvesting. 
2.3.3 STORAGE OF STRAINS. 
For day to day use strains were maintained on agar plates supplemented with 
antibiotics as required and stored at 4°C for three weeks. Long term storage of strains 
was achieved by mixing 0.5 m1 of an overnight culture with 0.5 m1 glycerol (20% final 
concentration) and storage at -80°C. 
2.3.4 BACTERIAL GROWTH CURVES. 
Overnight cultures ofKLC 4176, KLC 4177 and KLC 4178 were grown at 30°C in LB 
broth with aeration. Cultures of KLC 4178 were also supplemented with antibiotics as 
necessary. Following a 1: 1 00 dilution into fresh LB broth, cells from each strain were 
incubated at 30°C until Atioo was -0.2. Aliquots of these cultures were then incubated 
at 30 or 42°C (as per Galloway and Raetz 1990). Absorbances were measured every 
hour for ten hours and dilutions were spread plated onto LB or LB + Ap agar plates to 
determine numbers of viable bacterial cells at each absorbance measurement. Spread 
plates were counted after overnight incubation at 30°C. 
2.4 TECHNIQUES FOR STRAIN CONSTRUCTION. 
2.4.1 CALCIUM CHLORIDE TRANSFORMATIONS. 
2.4.1.1 Preparation of competent cells. 
E. coli strains were transformed using either the calcium chloride or electroporation 
method. Competent cells were prepared using a variation of the method of Sambrook 
et al. Briefly, overnight cultures of E. coli were diluted 1: 100 into 10 m1 of LB broth 
and incubated aerobically at the appropriate temperature to mid-log phase. Cultures 
were centrifuged at 10,000 rpm, 4°C, for 10 minutes, resuspended in one-half volume 
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of ice-cold 100 mM CaCh and incubated on ice for 60 minutes. Cell suspensions were 
centrifuged as above, resuspended in 1120 of the original volume with ice-cold 100 
mM CaCh and left to sit on ice for approximately 60 minutes before exposure to 
plasmid DNA. At this stage, aliquots of competent cells were used immediately, 
stored at 4°C overnight for next day use, or mixed with glycerol (final concentration 
20%) and frozen at -80°C for long term (6 months) storage. 
2.4.1.2 Transformation. 
0.5 Ilg of pre-chilled plasmid DNA was added to 100 III of ice-cold CaCh-competent 
cells, gently mixed and incubated on ice for 15 minutes. Cell mixtures were heat 
shocked at 42°C for 2 minutes without shaking before incubation at room temperature 
for a further 12-15 minutes. Transformants were diluted in 200 III LB broth and 
incubated at the appropriate temperature without shaking for 60 minutes to allow for 
protein expression (for example, antibiotic resistance proteins). Transformants were 
spread using a sterile glass rod onto LBA containing selective antibiotics and incubated 
at the appropriate temperature overnight. Well-isolated transformants were purified by 
streaking onto fresh LBA selective plates to obtain single colonies. Well-isolated 
single colonies were restreaked onto selective plates to obtain highly purified isolates. 
Plasmid DNA from these colonies was isolated as described below (section 2.6.2) and 
analysed using restriction endonucleases to verify the presence of the initial construct. 
2.4.2 ELECTROPORATION TRANSFORMATION. 
E. coli strains KLC 4176 and KLC 4177 were incubated at 30°C and not at 37°C as 
usual for the transformation procedures described below. 
2.4.2.1 Preparation of competent cells. 
Electroporation was found to be a more efficient method of plasmid DNA transfer into 
E. coli strains KLC 4176 and KLC 4177 than the calcium chloride method. 
Competent cells were prepared using a variation of the protocol supplied with the Bio-
Rad Gene Pulser (Bio-Rad, Richmond, CA). Cells from an overnight culture were 
initially diluted 1: 1 00 with LB broth, incubated aerobically at the appropriate 
temperature to early-mid log phase and chilled on ice for 20 minutes. Ice-cold cells 
were collected by centrifugation at 11,000 rpm, 4°C, for 10 minutes. The cell pellet 
was resuspended in one volume of ice-cold sterile distilled water (dH20) and collected 
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by centrifugation as before. The cell pellet was resuspended in 1/2 volume cold dH20 
before centrifugation as above. The pellet was resuspended in 1/50 volume sterile, ice-
cold 10% glycerol, transferred to a sterile l.5 m1 Eppendorf tube and centrifuged as 
before. At this stage the supernatant was carefully removed and the pellet suspended in 
1/500 of the original volume using sterile, cold 10% glycerol. 40 III aliquots of 
electrocompetent cells were used immediately or stored at -80°C in glycerol (20% final 
concentration) until required. When required, frozen cells were allowed to thaw on 
ice. All solutions were sterile and ice-cold to maintain competence. 
2.4.2.2 Electroporation. 
Sterile electroporation cuvettes (0.2 cm gap width) and the chamber slide were chilled 
on ice prior to electroporation. Thawed competent cells were mixed with 
approximately 100 ng of DNA and the mixture left on ice for 60 seconds. The mixture 
was transferred to an ice-cold cuvette, placed in the chilled chamber slide and pulsed in 
a Biorad Gene Pulser set to 25 IlF, 2.5 kV and with a resistance of 250 ohms. These 
settings usually generated a time constant between 3.9 - 4.6 msec. An 1 m1 aliquot of 
LB broth + glucose (20 mM final concentration) was added immediately to the 
electrically disrupted sample and the suspension was transferred to a sterile Eppendorf 
tube. Transformants were grown aerobically at the appropriate temperature for 60 
minutes with shaking and aliquots were spread using a glass spreader onto LBA + 
antibiotic plates. Plates were incubated overnight at the appropriate temperature. 
2.5 PROTEIN COMPLEMENTATION. 
2.5.1 TEMPERATURE-SENSITIVE COMPLEMENTATION. 
Successful complementation of the temperature-sensitive (ts) lpxA defect was 
determined by the ability of transformants to survive and replicate at the non-
permissive temperature of 42°C. E. coli strain KLC 4177 was transformed with a C. 
jejuni (F38011) plasmid expression library by electroporation and spread plated onto 
MM supplemented with His, Thr and antibiotics as necessary. Transformants were 
incubated at the permissive temperature (30°C) overnight. Transformants were replica 
plated onto MM supplemented with His and Thr containing antibiotics as required at 
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the non-permissive and permissive temperatures for 24-48 hours. The ability of a 
transformant to grow at 42°C on selective media indicated that the transforming 
plasmid expressed a gene encoding a protein which restored wild-type 
lipopolysaccharide expression. 
2.6 DNA Manipulation and Cloning Techniques. 
2.6.1 PREPARATION OF DNA. 
2.6.1.1 Preparation of total genomic DNA. 
The method of Berg et al. (1994) resulted in the greatest yield of chromosomal DNA 
from E. coli. A 48 hour streak plate of C. jejuni (approximately 1 x 109 cells) was 
overlaid with 3 rnl of solution 1 (see Appendix II) and the cells scraped into a sterile 30 
rnl centrifuge tube using a sterile glass spreader. Cells were centrifuged for 10 
minutes, 4°C, at 10,000 rpm. The pellet was suspended in 200 J.lllysozyme solution 
(10 mg/rnl) and incubated for 5 minutes at room temperature. 3 rnl of solution II was 
added, mixed by pipette and incubated for a minimum of 2 hours at 55°C. RNAase 
was added to a final concentration of 20 J.lg/rnl and the mixture was incubated for 10 
minutes at 55°C to degrade RNA. The solution was extracted with an equal volume of 
phenol/chloroform/isoamyl alcohol (25:24:1) and centrifuged for 10 minutes, 4°C, at 
10,000 rpm. The top layer was removed to a fresh Eppendorftube. A 1110 volume of 
3 M sodium acetate was added and the DNA was precipitated with two volumes 95% 
ethanol, centrifuged at 10,000 rpm, 4°C, for 10 minutes. The DNA pellet was washed 
in 70% ethanol, and air dried before dissolving the pellet in 100 J.lI of dH20. 
2.6.1.2 Method for Extraction of Chromosomal DNA from Campylobacter jejuni. 
(adapted from Giesendorf et al. (1994». 
The surface of a Mueller-Hinton agar plate (supplemented with 5-10% defribrinated 
sheep blood) containing a 48 hour streak culture of C. jejuni cells was scraped using a 
sterile glass rod and 10 rnl dH20 into a sterile 30 ml centrifuge tube. Cells were 
centrifuged for 10 minutes at 1500 x g at ambient temperature. Supernatant was 
removed and the bacterial pellet washed with 10 rnl sterile, cold dH20, and centrifuged 
as before. Supernatant was removed and cells resuspended in 10 ml sterile, cold 
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dH20. Cells were then aliquoted into 2 x 0.5 ml, 2 x 1.0 ml and 2 x 1.5 ml aliquots in 
1.5 ml Eppendorf centrifuge tubes to determine the volume of cells resulting in the 
highest yield of chromosomal DNA. Cells were centrifuged for 2 minutes at 12,000 x 
g, supernatants removed and the bacterial pellet resuspended in 150 III solution I (50 
mM glucose, 10 mM EDTA, 25 mM Tris, pH 8.0). 10 III of lysozyme (125 mglml) 
was added to the resulting solution and the cell lysates incubated at ambient 
temperature for 5 minutes. After addition of 12.5 III proteinase K (1 mg/ml) and 
12.5 III SDS (10% wt/vol), celllysates were incubated at 37°C for 30 minutes (volume 
at this stage approximately 185 Ill). Nucleic acids were extracted with an equal 
volume of Tris-saturated phenol (pH 8.0), vortexed, and centrifuged at 37°C for 5 
minutes before transfer of the aqueous phase to a clean Eppendorf tube. Nucleic acids 
were extracted two additional times with an equal volume of Tris-saturated phenol (pH 
8.0), vortexed, and centrifuged for 5 minutes at 4°C. The resulting supernatant 
containing the nucleic acids was precipitated with 0.1 volume 3 M sodium acetate (pH 
5.2) and 2.5 volumes 100% ethanol. 
Nucleic acids were collected by centrifugation for 10 minutes at 12,000 x g (4°C) and 
the pellet washed with 70% ethanol before resuspension in 100-200 III dH20 without 
RNAase. Samples were analysed by electrophoresis through an agarose gel (0.8%), 
stained with ethidium bromide and detected with UV light. Comparison of unknown 
concentration with known concentrations of 1 kb marker DNA were used to quantify 
samples. 
2.6.1.3 Alkaline Extraction of Plasmid DNA. (Sambrook et al. 1989). 
Plasmid DNA was extracted from bacterial cells as described below. 
An overnight culture was grown aerobically at the required temperature in 5 ml LB 
broth containing the appropriate antibiotics. 1.5 ml aliquots of the cells were 
centrifuged at 13,000 rpm (room temperature) for 1-2 minutes, supernatants removed, 
leaving the bacterial pellet as dry as possible. Bacterial pellets were resuspended in 
100 III of ice-cold solution I (Appendix I) by vigorous pipetting and left to sit at room 
temperature for 5 minutes. 200 III of solution II (Appendix I) was added and the 
contents mixed by inverting the Eppendorf tube rapidly five times, followed by 5 
minutes incubation on ice. The addition of 150 III ice-cold solution III was followed 
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by inversion of the tube rapidly ten times and the tube stored on ice for 5 minutes. 
Cellular debris was collected by centrifugation at 12,000 rpm (4°C) for 10 minutes, and 
the supernatant transferred to a fresh Eppendorftube. To extract protein contaminants 
from the plasmid DNA an equal volume of phenol/chloroform/isoamyl alcohol (IAA) 
was added, emulsified, and centrifuged at 12,000 rpm for 4 minutes at room 
temperature. The aqueous phase was transferred to a fresh tube where the plasmid 
DNA was precipitated by the addition of two volumes of 100% ethanol, mixed, and 
incubated at room temperature for 5 minutes. Plasmid DNA was collected by 
centrifugation at 12,000 rpm for 10 minutes at 4°C, washed with 1 rnl of 70% ethanol, 
and air dried before resuspending plasmid DNA in dH20 containing RNAase A (20 
~g/~l). 
For plasmid DNA that was to be sequenced, further purification was accomplished 
using the Geneclean III kit (Bio 101, La Jolla, CA) according to the manufacturer's 
protocol. 
2.6.2 RESTRICTION ENDONUCLEASE DIGESTION OF DNA. 
2.6.2.1 Restriction endonuclease digestions. 
Restriction endonuclease digestions were carried out according to the manufacturer's 
recommended protocol using supplied buffers. Generally, reactions were carried out in 
15 ~l final volumes and incubated for 2-3 hours at 37°C unless otherwise specified. 
F or digestions that employed more than one enzyme the most suitable buffer for the 
enzymes was used according to the manufacturer's protocol. 
2.6.2.2 Partial digests. 
Partial restriction enzyme digestions were used to clone segments of DNA where the 
restriction endonuclease sites occurred more than once within the DNA fragment. 
Reactions were carried out in 15 ~l final volumes and incubated at 37°C for 15, 30 or 
45 minutes. The degree of digest achieved was determined by visualisation of reaction 
products after electrophoresis and ethidium bromide staining. 
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2.6.3 DEPHOSPHORYLATION OF LINEARISED PLASMID DNA USING ClAP. 
To prevent the self-ligation of vector or insert DNA, calf intestinal alkaline 
phosphatase (ClAP) was added to restriction endonuclease digested DNA to remove 
5' phosphate overhangs. The final volume of the reaction mixture was 25 /-ll. The 
mixture contained 20 /-ll of genecleaned DNA (concentration about 2 mg/rnl of 
dsDNA), 2.5 /-ll of lOx dephosphorylation buffer (Boehringer Mannheim), 1 /-ll of 
ClAP (Boehringer Mannheim) and dH20 making up the remaining volume. The 
reaction mixture was mixed thoroughly and incubated at 37°C for 1 hour before heat 
inactivation (incubation at 65°C for 10-20 minutes) of ClAP. 
2.6.4 DNA LIGATION. 
Ligation was performed in a total volume of 20 /-ll. 1 /-ll of T4 DNA ligase (Gibco-
BRL or Promega) and 4 /-ll of 5x DNA ligase buffer (Gibco-BRL or Promega) were 
used to ligate vector DNA to a desired DNA fragment. Ligation mixtures were 
incubated overnight (12-24 hours) at 12°C. Ligation efficiency was usually checked by 
UV visualisation of ligation products after agarose gel electrophoresis and ethidium 
bromide staining, before ligated DNA was transformed into electro competent cells. A 
vector DNA to insert DNA ratio of 1:3 was favoured for high intermolecular ligation 
and low concatamer formation. 
2.6.5 AGAROSE GEL ELECTROPHORESIS OF DNA. 
2.6.5.1 Gel Electrophoresis. 
Agarose dissolved in Ix T AE buffer (appendix 2) was used for gel electrophoresis of 
DNA. The agarose content varied between 0.8% for restriction endonuclease digested 
DNA fragments, to 2% for small (less than 800 bp) peR products. DNA was mixed 
with 2-3 /-ll of 6x bromophenol blue gel dye before loading into the agarose gel. DNA 
fragments were separated by exposure to an electrical current of 65 volts/cm2 for 1.5-
2.5 hours in a Bio-rad mini sub or DNA sub cell apparatus. Ethidium bromide (0.5 
/-lg/ml) in Ix TAE was used to stain gels for 10-20 minutes. DNA bands were 
visualised using a Sigma T2210 UV Transilluminator (302 nm). Known 
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concentrations of 1 kb marker DNA were used as a standard reference of DNA size 
and concentration. 
2.6.5.2 Elution of DNA Fragments from Agarose Gels. 
After visualisation of DNA on an agarose gel by ethidium bromide staining and UV 
transillumination, desired fragments were excised from agarose using a sterile scalpel 
blade and placed into sterile 1.5 ml Eppendorf tubes. DNA was extracted from the 
agarose matrix using the Geneclean III kit (Rio 101, La Jolla, CA) according to the 
manufacturer's instructions. DNA was eluted from the silica (Glassmilk) matrix using 
dH20. A modification to the manufacturer's protocol was to add a third elution step 
to ensure complete absence of the silica matrix from the eluted DNA. 
2.7 PLASMID CONSTRUCTS. 
Plasmids containing colE1 replication origins commonly used for molecular biology 
(such as pBIISK(+), pGEM-T) were used as vectors for the insertion of foreign DNA 
segments. These constructs were used for temperature-sensitive mutational 
complementation, DNA sequencing analysis and Southern hybridisation, as well as for 
use in protein expression analyses. This section describes the important plasmids 
constructed in this study. 
pCIl-pCIS 
C. jejuni F38011 chromosomal DNA was partially restriction endonuclease digested 
with Sau3A and analysed by agarose gel electrophoresis followed by ethidium bromide 
staining and UV detection. DNA fragments ranging from 2-3 kb were excised from 
the agarose, the agarose removed and the resultant DNA ligated into the unique 
BamHI site of pBIISK(+). Each construct complements the ipxA mutation in KLC 
4177. Apr. 
pCI6 
A 0.8 kb PCR amplicon of C. jejuni strain NZRM 1958 was amplified by PCR using 
primers 96-24 and 96-25 (see table 4) and ligated into vector pGEM-T. Used for 
sequencing. Apr. 
Chapter II Materials and Methods 43 
Templates were needed for sequencing and these were generated by partial restriction 
endonuclease digests of pcn using EcoRI and HindIlI in separate digests. 
pCIlOI-I04 
pcn was restriction endonuclease digested with EcoRI for 15 minutes and the 
resultant fragments were allowed to religate in the original vector. Used for 
sequencing. Apr. 
pC1l11-114 
pcn was restriction endonuclease digested with HindIlI for 15 minutes and the 
subsequent fragments were allowed to religate in the original vector. Used for 
sequencing. Apr. 
2.8 SEQUENCING. 
DNA sequencing of the lpxA gene of C. jejuni F38011 was achieved by the Sanger 
dideoxy sequencing method (Sanger et al. 1977). Part of the nucleotide sequence of 
the JabZ-lpxA gene segment was obtained using an Applied Biosystems Model 733A 
version 1.2.0 automated sequencing apparatus at the Centre for Gene Research, 
Biochemistry Department, University of Otago. Plasmids used for sequencing 
containing inserts of the lpxA gene of C. jejuni of varying lengths, were prepared from 
either E. coli strains KLC 4000 or KLC 4177. Both of these strains gave a good yield 
of plasmid DNA. Primers used for sequencing are listed in table 4. DNA templates 
sequenced by the Sanger method were prepared for electrophoresis using reagents and 
enzymes supplied with the Sequenase Version 2.0 DNA sequencing kit (Amersham). 
[a-35S]dATP was purchased from NEN Life Science Products or Amersham. 
2.S.1 TEMPLATE PREPARATION. 
Plasmids used as templates for Sanger sequencing were prepared to a high level of 
purity. This was accomplished by first obtaining the plasmid from strains via alkaline 
lysis and then removal of all trace amounts of phenol via use of the Geneclean III kit 
(Bio 101, La Jolla, CA) according to the manufacturer's protocol. Double stranded 
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plasmid DNA template was denatured into single stranded DNA by addition of 1 N 
NaOH and mixed gently before incubation at room temperature for 5 minutes. 
2.8.2 PRIMER ANNEALING. 
To the above solution the following reagents were added sequentially: single stranded 
DNA sequencing primer (30 pmol), 3 M potassium acetate (pH 4.5) (final 
concentration 0.45 M), and dH20 to a total volume of20 Ill. Each reagent was mixed 
thoroughly by gentle pipetting upon addition to the solution. The resulting solution 
was precipitated immediately with 1 volume isopropanol, mixed, and incubated, for 
5 minutes at 4°C. Reactions were centrifuged for approximately 10-12 minutes at 
12,000 rpm, 4°C, and resultant pellets washed with 70% ethanol. The resulting pellet 
was air dried at 37°C and resuspended in 12 III of 1 x sequenase buffer. At this stage 2 
III of the template mix was removed and analysed by electrophoresis through a 0.8% 
agarose gel, ethidium bromide stained and UV visualised to determine the presence 
and concentration of plasmid DNA. This was done to ensure that there was no loss of 
DNA due to the process. Annealed templates were usually labelled immediately. 
Table 4. Primers used for PCR and sequencing. 
Primer name 
pUC Forward 
pUC Reverse 
96-24 
96-25 
Sequence 
5' -GT AAAACGACGGCCAGT 
5' -GGAAACAGCTATGACCATG 
5' -GCTCTACT AAGTCTATCT 
5' -GTCCGTCCTGGAGATAGGC 
2.8.3 LABELLING REACTIONS. 
Target gene/organism 
plasmid vector pBIISK( +) 
plasmid vector pBIISK( + ) 
lpxA in C. jejuni F38011 
JabZ in C.jejuni F38011 
To the annealed DNA template-primer mix, the following reagents were added: 1 III of 
DTT (0.1 M), 2 III oflabelling nucleotide mix (dGTP), and 0.5 III [a-35S]dATP. Each 
reagent was mixed thoroughly before the addition of 2 III Sequenase Enzyme 2.0 
(diluted 1:8 in sequenase dilution buffer, Amersham). Reactions were pulsed in a 
microfuge and incubated for 5 minutes at room temperature. 
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2.5 III of the individual dideoxy termination nuc1eotides (ddG, ddA, ddT, ddC) were 
added to tubes labelled 'G', 'A', 'T', or 'C', and pre-warmed to 37°C. 3.5 III of the 
completed labelling reactions were added to each of the four tubes 'G', 'A', 'T', and 
'C' and incubated at 37°C for 5 minutes. Reactions were stopped by the addition of 
4 III of Stop Solution. Completed reactions were stored on ice if they were to be used 
immediately or at -20°C until use. All sequencing samples were denatured at 95°C for 
3 minutes before loading onto 5% polyacrylamide gels containing urea. 
2.8.4 ELECTROPHORESIS AND AUTORADIOGRAPHY. 
Electrophoresis of dye sample through 5% denaturing polyacrylamide gels containing 
urea was performed for 20 minutes at 1750 volts. DNA samples were heated to 95°C 
for 3 minutes and 3 III of each sample was loaded into the appropriately designated 
well in the gel (21 cm x 40 cm) and samples were electrophoresed at 1700-2000 volts 
for approximately 3 hours. Ix TBE was used as the electrophoresis buffer. Once 
electrophoresis was completed, plates were separated and the PAGE gel was fixed 
(10% acetic acid and 10% isopropanol) for 15 minutes before being dried on to 
Whatman 3 mm paper at 80°C for 2-5 hours using a Dry Gel Sr slab gel drier SE1160 
(Hoeffer Scientific Instruments, San Francisco). Labelled DNA was then visualised in 
one of two ways. Method one involved exposing the dried sequencing gel to Kodak 
Autoradiography film for 2-3 days in an autoradiography cassette before development 
of the film. The film was developed in Agfa G-150 developer for 5 minutes, washed in 
water for 1 minute, and the image fixed in Agfa G-334 fixer for five minutes. Fixed 
autoradiographs were rinsed in water and air dried. In the second method dried gels 
were used to expose a STORM (Molecular Dynamics) phosphoimager screen (covered 
in gladwrap) for 12-24 hours. This screen was scanned using red beam fluorescence at 
635 nm and the image analysed on an Apple Macintosh using ImageQuant software. 
2.8.5 COMPUTER SOFTWARE FOR DNA SEQUENCING ANALYSIS. 
Computer software used for analysing DNA sequence obtained from sequencing gels 
consisted of three programs: DNASIS, CLUSTALV and BOXSHADE. DNASIS was 
used for nucleotide comparison of the various sequences. CLUST AL V and 
BOXSHADE performed multiple sequence alignment of the various translated 
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sequences and identified similar and conserved proteins. The BLAST database was 
used for comparison of C. jejuni nucleotide sequence/protein sequence to that of other 
organisms. 
2.9 POLYMERASE CHAIN REACTION (PCR). 
PCR of both plasmid and chromosomal DNA was carried out usmg a Corbett 
Research FTS-320 Thermal Sequencer. Buffers, dNTPs and enzymes were purchased 
from Gibco-BRL, and primers were purchased from Amrad-Pharmacia (Table 4). 
2.9.1 PCR AMPLIFICATION OF DNA TARGETS. 
2.9.1.1 PCR of plasmid DNA. 
0.5 III thin-walled PCR tubes were used for each reaction. For each PCR reaction 
approximately 100 ng/ml of plasmid DNA was used. Primers were diluted 1: lOin 
dH20 to give a final concentration of 30 pmo!. dNTPs were diluted to give a final 
concentration of 0.08 mM each (ddG, ddA, ddT, ddT) per reaction. For the PCR mix, 
5-10 III of template DNA was added to 12 III of the dNTP mix and 5 III of each 
primer. To this was added 15 III of lOx PCR buffer (Mg2+ free), 12 III of 25 mM 
MgCb (final concentration 2 mM) and ddH20 up to a final volume of 149.5 Ill. 0.5 III 
of Taq DNA Polymerase was added to each tube and the mixture gently mixed, pulsed 
briefly in a microfuge and overlayed with 100 III of paraffin oil. The DNA was 
amplified for 32 cycles in the thermal cycler. Each amplification cycle consisted of 
three steps: denaturation for 1 min at 94°C, annealing for 1 min at 37°C (55°C if 
homologous DNA was used depending on Tm of primer - Tm of primers was often 
less than 55°C), and extension ofPCR product for 1.5 min at 72°C. An initial cycle of 
94°C for 3 min was performed So that the target DNA was completely denatured. The 
program concluded with a soak step that incubated the tubes at 4°C before removal for 
storage at 4°C or -20°C, minus paraffin oil. 5-10 III from each PCR reaction was 
loaded on a 2% agarose gel, subjected to an electrical field (50-100 V/cm\ and 
stained with ethidium bromide before visualisation by UV to observe the sizes of PCR 
products. 
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2.9.1.2 PCR of Chromosomal DNA. 
PCR reactions either utilised as a template extracted chromosomal DNA or whole 
bacterial cells (colony-PCR). For extracted chromosomal DNA the PCR method is as 
for plasmid DNA. For whole cell PCR reactions, a colony of bacteria (about 106 cells) 
was selected from a spread plate and dispersed in the reaction mix described for PCR 
of plasmid DNA minus the lOx buffer (Mg2+ free) and Taq. This mix was boiled for 10 
minutes, briefly cooled to room temperature and mixed with lOx buffer containing Taq 
DNA Polymerase. Each tube was gently mixed, pulsed briefly in a microfuge and 
overlaid with 100 /-ll paraffin oil. Amplification conditions were as described for 
plasmid DNA. 
2.10 MAXICELL ANALYSIS OF PLASMID ENCODED 
PROTEINS. (Silhavy et al. 1984) 
Bacterial proteins were analysed using the method of Silhavy et al. (1984). Briefly, 
cells of strain KLC 4026 were made calcium chloride competent and transformed with 
the plasmid of interest. Transformants were incubated in the dark at 37°C on LBA 
containing antibiotic supplements. Transformants were purified before proceeding 
with the maxi cell protocol. Culture tubes containing 5 ml M63 medium, 1 % casamino 
acids, 0.4% glucose and the appropriate antibiotic, in this case ampicillin, were 
inoculated with a single colony of the transformant and incubated overnight at 30°C 
with aeration. KLC 4026 and KLC 4027 were used as controls. On day 2, 0.2 ml of 
the overnight culture was inoculated into 11 ml of the M63 medium, supplemented as 
above and shaken at 37°C until the culture reached an OD6oo of 0.7. The cells were 
irradiated in the dark with a UV light dose of 300 erg/mm2, with occasional mixing. 
10 ml of irradiated cells were inoculated into a foil-wrapped flask and shaken for 30 
minutes at 37°C before addition of 40 I-ll of a 50 mg/ml stock of cycloserine, and 
incubation continued overnight. On day 3, 0.1 ml of cells were spread onto an LBA 
plate supplemented appropriately and incubated overnight at 37°C to check for 
survivors; the rest of the cells were collected by centrifugation at 1500 g for 10 
minutes before resuspension in 10 ml of M63 medium. Cells were recentrifuged at 
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1500 g for 10 minutes, resuspended in 2 m1 ofM63 medium containing 0.4% glucose, 
and incubated at 37°C for 1 hour with aeration. After the addition of 10 III of [35S] 
methionine (25-100 /lCi/ml) to the cells incubation was continued at 37°C for 30 
minutes, before centrifuging at 1500 g for 10 minutes and the unincorporated 
radioactive supernatant discarded. The cell pellet was resuspended in 0.5 m1 ofM63 
medium and transferred to a sterile 1.5 m1 Eppendorf tube and centrifuged for 5 
minutes in a benchtop microfuge at 13 000 rpm. Supernatant was discarded, the cells 
resuspended in 0.5 ml M63 medium and centrifuged for 5 minutes at 13 000 rpm in a 
benchtop microfuge. The supernatant was discarded and the cell pellet resuspended in 
0.1 ml of 2 x loading buffer. Tubes containing the cells were boiled for 5 minutes in a 
waterbath before storage at -20oe, in preparation for electrophoresis on an SDS-
polyacrylamide gel (SDS-PAGE). 
2.10.1 SDS-PAGE (Silhavy et al. 1984). 
Proteins were separated by electrophoresis through a 12% polyacrylamide gel (16 x 20 
x 0.75 cm) comprised of a 12% acrylamide separating gel and a 3% stacking gel in a 
Hoeffer SE600 gel apparatus (Hoeffer) using a sodium dodecyl sulphate 
(SDS)t-tglycine running buffer system for both top and bottom buffers. Continuous 
voltage at 100 volts/cm2 was carried out through the stacking gel until the dye front 
reached the separating gel. At this point voltage was increased to 200 volts/cm2 and 
the protein samples electrophoresed until the dye front (bromophenol blue) migrated to 
the bottom of the gel. The acrylamide gel was removed from the glass plates and 
placed in coomassie brilliant blue stain for 30-60 min before destaining. The gel was 
destained initially for 15 minutes in a 5% methanol and 7% acetic acid solution with 
gentle shaking. Destaining solution was discarded, fresh solution added and gels were 
gently shaken for 1 hour. Used destaining solution was discarded, fresh solution was 
added and gels were left in the destain solution overnight. After destaining steps, the 
protein gel was placed on an acetate and photographed. In a second method, dried 
gels were used to expose a STORM (Molecular Dynamics) phosphoimager screen 
(covered in gladwrap) for 12-24 hours. This screen was scanned using red beam 
fluorescence at 635 nm and the image analysed on an Apple Macintosh using 
ImageQuant software. 
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2.11 SOUTHERN HYBRIDISATION. 
2.11.1 SOUTHERN TRANSFER. 
DNA was digested to completion (usually a minimum of five hours) and separated by 
electrophoresis through a 1 % agarose gel in a DNA sub cell or Biorad mini sub cell 
apparatus. Ethidium bromide (0.5 j.lg/ml) in 1 x T AE was used to stain gels for 20-30 
minutes and gels were photographed using a Sigma T2210 UV Transilluminator (302 
om) using 1 kb marker as the standard. DNA was transferred to a lOx 15 cm nylon 
membrane (Boehringer Mannheim) using a Hoefer Trans-Vac TE80 vacuum blotter 
attached to a Cole-Parmer Air Cadet vacuum/pressure station at a negative pressure of 
125 mm Hg (-15 kPa). The next three steps were also performed under vacuum. 
Nylon membranes containing DNA were soaked in depurination solution (appendix II) 
for 10 minutes prior to removal and the addition of denaturation solution (appendix II) 
to the membrane which was left to soak for a further 10 minutes. Denaturation 
solution was removed and the membrane exposed to neutralisation solution (appendix 
II) for 10 minutes before removal of the neutralisation solution. DNA was transferred 
in 20 x SSC for 60 minutes. The agarose gel was restained in ethidium bromide and 
visualised on a UV transilluminator to determine the efficiency of transfer. The 
membrane was gently blotted dry using Whatman 3 mm paper. Single stranded DNA 
was cross-linked to the membrane by exposure to UV for 30 seconds at 1200 kJ in a 
UVC-515 Ultraviolet Multilinker (Ultra-Ium). Membranes were either probed 
immediately or wrapped in foil and stored at room temperature until required. 
2.11.2 PROBE LABELLING AND HYBRIDISATION. 
The non-radioactive digoxigenin-dUTP (DIG) DNA labelling and detection kit 
(Boehringer Mannheim) was used for all Southern hybridisations. The labelling 
reaction was carried out as follows: to 300 ng ofphenollchloroform-purified DNA in a 
1. 5 ml micro centrifuge tube ddH20 was added to make a final volume of 16 j.ll. DNA 
was denatured by placing the tube in a boiling waterbath for 10 minutes. The tube was 
immediately placed on ice for 5 minutes before the addition of 4 j.lI DIG High-Prime to 
the denatured DNA. Contents of the tube were mixed by gentle tapping or pipetting 
and briefly centrifuged in a micro centrifuge before incubation at 37°C overnight to 
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ensure the greatest yield of DIG-labelled DNA. A colourimetric test was used to 
check efficiency of incorporation of DIG into the probe DNA. Dilutions of probe 
DNA were visually compared to known amounts of DIG-labelled DNA contained on a 
test-strip, and the amount of DIG-labelled probe was calculated based upon the known 
concentrations of DNA on the test-strip. 
2.11.3 PRE-HYBRIDISATION. 
Hybridisations were performed as described in the DIG users manual (Boehringer 
Mannheim). Membranes were placed in a roller hybridisation bottle containing 10 ml 
of DIG Easy Hyb and incubated at 42°C in a Hybaid LTD Micro-4 HB-MCR4 for 2 
hours. The amount of probe required for 10 ml hybridisation buffer to give a final 
concentration of 25 nglml was calculated. The probe volume was made up to 50 ~l 
with ddH20 and the probe denatured in a boiling waterbath for 10 minutes and placed 
immediately on ice. 
2.11.4 HYBRIDISATION. 
The 1.5 ml microfuge tube containing the probe was briefly centrifuged In a 
microcentrifuge before addition to 15 ml of fresh DIG Easy Hyb that had been 
prewarmed to 42°C. The hybridisation solution containing the probe was filtered using 
a 0.45 ~m nitrocellulose disposable filter into a sterile universal bottle. Membranes 
were left in hybridisation solution overnight at 42°C with constant rotation. Following 
hybridisation, membranes were removed from the hybridisation solution and washed 
for 15 minutes in low stringency wash buffer (2 x SSC, 0.1 % SDS) at room 
temperature with occasional shaking. Care was taken to not allow membranes to dry 
out. This wash was repeated with fresh solution. This step is performed to remove 
unbound probe. Membranes were washed further (twice for 15 minutes) in high 
stringency buffer (0.5 x sse, 0.1% SDS) at 68°e with constant shaking. After 
performing stringency washes, membranes were rinsed briefly (1-3 minutes) in 1 x 
washing buffer (50-100 ml to equilibrate) before incubation for 30 minutes at room 
temperature in 1 x blocking solution (see Appendix 2). Anti-DIG-AP conjugate 
( antibody) was centrifuged for 5 minutes at 10 000 rpm before being diluted 1: 10000 
in 1 x blocking solution. Membranes were incubated in diluted antibody solution for 
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30 minutes in a separate, clean container, washed twice (for 15 minutes) in 1 x 
washing buffer, and equilibrated for 2-5 minutes in 1 x detection buffer. The 
membrane was placed on an acetate (DNA side up) and 20 drops (approx. 1 ml) of 
CSPD, ready-to-use solution, was applied, dropper-form, along the side of the 
membrane and the membrane was immediately covered with a second acetate and 
CSPD spread evenly over the membrane with a damp cloth. After incubation at room 
temperature for 5 minutes any excess substrate was squeezed out at the edges of the 
acetate sandwich and sealed, using a heat-sealer. The damp membrane was incubated 
at 37°C for 15 minutes to enhance the luminescent reaction, before the acetate was 
wiped down with 70% ethanol and exposed to Lumifilm (in the dark room) for 30 
minutes at room temperature and developed. 
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RESULTS. 
3.1. Cloning of a functional analog of the E. coli gene lpxA from 
Campylobacter jejuni. 
3.1.1. SCREENING OF A C. jejuni PLASMID LIBRARY FOR IpxA 
FUNCTIONAL ANALOGS. 
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A plasmid expression library made from C. jejuni F38011 DNA cloned into the vector 
pBIISK(+) was obtained from Dr. M. E. Konkel (Washington State University). The 
expression library was constructed from a partial Sau3A digest of C. jejuni F38011 
genomic DNA, with subsequent Sau3NSau3A fragments ligated into the BamHI site 
of pBIISK( +). The library consisted of either F3 80 11 DNA inserts of 2-3 kb (F2) or, 
in the case ofF3, 3-4 kb inserts of F38011 DNA. This library has been successfully 
used to isolate several LPS and non-LPS genes from C. jejuni (Konkel et al. 1996; 
1. Klena, pers. comm.). 
3.1.2 TEMPERATURE-SENSITIVE MUTANT: SELECTION FOR GROWTH AT 
42°C. 
KLC 4177 is a temperature-sensitive strain of E. coli K 12 that lacks the ability to 
produce the enzyme UDP-N-acetylglucosamine acyltransferase, the protein product of 
the lpxA gene, at 42°C but not at 30°C. Due to this defect in lipid A synthesis, KLC 
4177 is unable to grow on MM supplemented with His and Thr at the non-permissive 
temperature of 42°C (figure 7). In order to identify a gene whose product is capable 
of restoring viability of KLC 4177 temperature-sensitive mutants at 42°C, the F3 80 11 
plasmid library was transformed into KLC 4177. The plasmid expression library was 
introduced into electro-competent KLC 4177 cells and transformants were selected on 
MM supplemented with His, Thr and Ap at 30°C. 
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Figure 7. Growth phenotype of E. coli strains KLC 4176 and KLC 4177 at 30°C and 42°C. Strains 
were incubated on MM supplemented with His, Thr and Ap at 42°C (A) and 30°C (B). KLC 4176 
(wild-type) is shown on the left and the temperature-sensitive mutant KLC 4177 on the right of each 
plate. 
Figure 8. Growth phenotype of transformants KLC 4178-4182 showing viability at both 30°C and 
42°C. Strains were incubated on MM supplemented with His, Thr and Ap at 30°C (A) and 42°C (B). 
KLC 4178 - KLC 4182 are labelled 1-5 respectively on each plate. 
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This was done to ensure that viable transformants were produced and contained a 
plasmid enabling them to survive ampicillin selection at the permissive temperature. In 
order to select transformants containing a lpxA analog, transformants were replica 
plated to two plates of MM + His, Thr and Ap; one plate was incubated at 30°C 
(permissive) while the other replica plate was incubated at 42°C (non-permissive). 
Restoration of the ability of transform ants to replicate at 42°C should be indicative of a 
gene product from C. jejuni F38011 that overcomes the IpxA defect in E. coli K12. 
From the thousands of transform ants screened at both 30°C and 42°C (data not shown) 
five Apr transformants of KLC 4177 generated with the F2 expression library arose at 
42°C (KLC 4178-KLC 4182) (figure 8). Plasmid DNA isolated from these 
transformants was designated pCI1, pC12, pCB, pC14, and pC15. The control plate 
containing KLC 4177 cells transformed with pBIISK( +) alone produced growth at 
30°C but not at 42°C. 
To ensure that the ability to grow at 42°C was due to genetic determinants expressed 
from the plasmids and not reversion of the lpxA mutation in KLC 4177, electro-
competent KLC 4177 cells were transformed with plasmids pCI1-5 and selected on 
MM + His, Thr and Ap a second time. If growth at 42°C is due to reversion and this 
event is infrequent in a population (as the lpxA mutation is tight), then a difference 
should be seen in the number of transformants arising at 42°C compared to provision 
of complementing activity from a plasmid (in trans). In other words, all transformants 
receiving a complementing plasmid should grow at 42°C, while only a small population 
of cells in a population with a revertant (depending on when reversion occurred) 
should arise at 42°C. Strain KLC 4177 was taken from fresh stock each time it was 
needed and shown to be unable to form colonies at 42°C to ensure that parental stocks 
had not reverted. Colony formation was determined at both 30°C and 42°C and in all 
five cases each transformant arising originally at 30°C, containing either pCI1 through 
to pC15, was able to replicate at 42°C. Growth ofKLC 4177 transformants containing 
pBIISK(+) were observed at 30°C only indicating no reversion in the lpxA parental 
strain during cell competence preparation. In calcium chloride transformations ofKLC 
4177 with pCI1-pCI5, approximately 600 transformants arose containing pCI1 and 
pCl4 at 30°C and at 42°C. It was observed that fewer transformants arose at 30°C 
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and 42°C containing the plasmids pCI2 and pCIS, and that no transformants grew 
containing pCB at 30°C and 42°C. The fewer number of transformants for plasmids 
pCI2 and pCIS and the lack of transformants from pCB may have been due to the 
efficiency of the transformation technique, or perhaps the quality of the plasmid 
preparation used. However when visualised by agarose gel electrophoresis and 
ethidium bromide staining, pCB appeared as concentrated as all other pCI plasmids 
used. From electroporation transformation data, KLC 4177 transformants containing 
plasmid pCB arose at a lower frequency relative to the other pCI plasmids as 
determined by visual observation of colony numbers both at 30°C and at 42°C. 
Several reasons might explain this: 1) the C. jejuni DNA fragment containing lpxA on 
these plasmids may also contain a gene whose product is toxic to E. coli; 2) a partial 
gene contained on the clone may produce an incomplete product and this product 
interferes with E. coli growth; or 3) possibly the most interesting theory is perhaps the 
presence of a gene whose product can modify the LPS of E. coli in such a fashion that 
growth may occur, but this is due to synthesis of a novel lipid A species or 
intermediate and not lpxA complementation. This last scenario would be most exciting 
as it might enable genes involved in assembly of other lipid A analogs in C. jejuni to be 
identified. 
3.1.3 RESTRICTION ENZYME MAPPING OF pCIl-S. 
Restriction endonuclease digestions were carried out on plasmids pCIl-S using a 
number of different enzymes. The purpose of these digestions was to determine if a 
common fragment existed among the cloned C. jejuni inserts. A common fragment 
within the inserts may rule out one or two of the scenarios stated earlier, and perhaps 
indicate where the gene responsible for complementary activity is located. 
A double digest with KpnI and SacI was performed to determine sizes of the C. jejuni 
F38011 chromosomal DNA inserts within pCIl-pCIS as these two enzymes are known 
to digest DNA on either side of the insert (see figure 10 ofpCIl). Insert sizes differed 
for all five plasmids. The insert in pCIl was shown to be 1. 4-1. 6 kbp in size; pCI2 
produced three fragments, two of approximately 2.9 kb and one of 300 bp; pCB 
generated three fragments from the digestion, two of 2.9 kb and one of 450 bp; the 
fragment ofpCI4 was 2.7-2.8 kb in size; and the insert seen in pCIS was 2.5 kb (figure 
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9). From the pattern observed for pCI2 and pCB the insert has probably been cut 
twice by either KpnI or Sad. 
1 2 3 4 5 6 
-3,0 
-1'5 
-0,5 
Figure 9. Plasmids pCIl-pCIS restriction endonuclease digested with Kpnl and Sad to visualise the 
C. jejuni F38011 DNA insert from the plasmid vector pBIISK(+). Lane 1, pCIl; Lane 2, pC12; Lane 
3, pCB; Lane 4, pC14; Lane S, pCIS; Lane 6, 1 kb standard marker. Sizes (kb) of the bands in lanes 
I-S were estimated by comparing migration of digested DNA to that of the known 1 kb standard 
migration. DNA was electrophoresed on a 0.8% agarose gel, stained with ethidium bromide and 
visualised under UV light. Bands larger than 3 kb are due to uncut or partially digested plasmid 
DNA. Bright bands at the bottom of the gel are indicative of RNA that has not been completely 
removed by RNAase A. The uniform band at approximately 3.0 kb is the vector pBIISK(+). 
Subsequent restriction endonuclease digestions of these plasmids with the enzymes. 
EcoRI and HindIII in separate digests revealed that pCll was digested 4 times by 
EcoRI; once in the pBIISK( +) vector and three times within the insert, resulting in 
DNA fragments of approximately 3.2 kb, 700 bp, 500 bp and 50 bp (summarised in 
figure 10). From the HindIII digestion ofpCll, the enzyme cut five times, once in the 
vector and four times in the inserted fragment generating 3 kb, 900 bp, 400 bp, 200 bp, 
and 150 bp DNA fragments (figure 10). As the vector is 3.0 kb itself, the addition of 
the other bands suggested an insert of 1.4-1.6 kb in size for pCll. Plasmids pCl2 and 
pCB restriction endonuclease digested with EcoRI and HindIII in separate reactions 
displayed a similar banding pattern to each other when analysed by agarose gel 
electrophoresis. A doublet of 2.9-3.0 kb in size was observed in both pCl2 and pCB 
suggesting that the inserts within these plasmids are approximately twice the size of the 
insert in pCll. The digestion pattern for pCl2 and pCB also indicates that each insert 
must contain only a single EcoRI and HindIII site. When plasmids pCl4 and pCIS 
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were digested each revealed a unique restriction pattern. pCI4 digested with EcoRI 
generated at least a 3 kb, 800 bp and 600 bp fragment. pCI4 was cut five times with 
HindIII producing fragments 3 kb, 900 bp, 700 bp, 200 bp and 150 bp in size. pCIS 
was cut twice by EcoRI, once in the vector and once in the insert, generating a 3 kb 
and a 600 bp doublet fragment, as well as a 4.5 kb fragment which may be the result of 
uncut or only partially digested DNA. The HindIII profile for pCIS showed a doublet 
at 3 kb and two smaller fragments at 900 bp and 400 bp. When the sizes of the EcoRI 
and HindIII fragments were summed up and compared for pCI4 and pCIS they did not 
agree (data not shown). 
Restriction mapping revealed only one common fragment for all five plasmids; the 
vector, pBIISK( +). pcn appeared to contain the smallest, most consistently sized C. 
jejuni insert capable of restoring growth at the non-permissive temperature in KLC 
4177. pcn also contained many restriction endonuclease sites not present in the other 
five plasmids. Although both pCI2 and pCB generated similar restriction enzyme 
fragments, it was shown by the digestion with Kpnl and SacI that the two plasmids 
contained different sized inserts. Common fragments shared by plasmids were the 900 
bp, 400 bp and 150 bp HindIII fragments observed for pcn and pC14. 
As a result of the data generated from the restriction endonuclease digests and the 
growth of transformants on MM, plasmids pCll and pCI4 were chosen for further 
analysis as they were the plasmids containing the least amount of C. jejuni DNA with 
the most restriction sites (important for ease of sequencing and manipulation), shared 
sizes of some restriction fragments and appeared to produce the best complementation 
(shown by the greatest number of transformants). Time was too limited to take a 
closer look at all the other plasmids to determine the differences between them. 
3.2 Characterisation of pCI1 and pCI4 F38011 chromosomal DNA. 
3.2.1 RESTRICTION MAPPING. 
Plasmids pcn and pCI4 were further digested with the following restriction enzymes, 
BamID, Bgnl, BstXl, Ddel, and EcoRV, to construct a physical map. 
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Results generated for pcn included internal restriction enzyme sites for BglII, BstXl, 
DdeI, and EcoRV (see figure 10). When pcn was digested with BstXl, two 
fragments, 3.5 kb and 1.0 kb, were generated, indicating that the enzyme has a 
restriction site within the insert as well as the site known within the vector. EcoRV 
appeared to cut once within the insert of pcn and once in the vector, producing bands 
of 1.5 kb and 3.0 kb. The restriction enzyme DdeI cut within pcn a number of times 
producing bands of 600 bp, 500 bp and 400 bp as well as many smaller fragments 
which were difficult to resolve due to contaminating RNA. As expected Sau3A cut a 
number of times within the insert generating many fragments of varying sizes. 
Initially, pCI4 had an unusual restriction pattern; when digested with HindlII, SacI, 
EcoRI, XhoI and EcoRV, doublets of fragments were observed ranging in size 
between 3-5 kbp. This was unexpected as the average size of the inserts in the F2 
library are between 2-3 kb and the fragments observed for pCI4 were much larger than 
2-3 kb. EcoRI and EcoRV digests of pCI4 DNA also produced smaller sized 
fragments of 0.5 kbp-1.5 kbp as well as the 3-5 kbp fragment. An explanation for 
these unexpected restriction patterns is that there may have been two plasmids present 
within the original colony and both were isolated initially, resulting in restriction 
profiles that were similar to each other but not identical. Further purification of the 
pCI4 plasmid followed by restriction endonuclease digests have resulted in the 
disappearance of the plasmid fragment sized at 3-5 kbp. This lends further support to 
the hypothesis of two plasmids being initially isolated and digested. 
PCR was performed using pcn and pCI4 and the pUC forward and reverse primers as 
another method to help in determining of sizes of the insert within these plasmids. For 
pcn a PCR fragment was observed measuring 1.5 kbp in size. For pCI4, a PCR 
fragment of 1.9 kb was observed, close to the size of the fragment produced from the 
restriction digest mapping (data not shown). For pcn, the restriction digestion 
patterns using EcoRI and HindlII and the results from PCR were encouraging as they 
were consistent with the mapping studies done above. The patterns consistently 
showed an insert of 1.4-1.6 kbp and identical placement of restriction sites (HindlII, 
EcoRI) in pcn (data not shown). Due to the initial difficulties encountered with 
pCI4, plasmid pcn was chosen for further analysis. 
pUCR 
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Figure 10. Linear map showing C. jejuni F38011 DNA insert in pCIl. One complete and two partial 
ORFs are contained on the fragment; a portion of the citrate synthase gene (cdh); the 3' end offabZ; 
and the /pxA gene. Arrows show direction of transcription. Letters in boxes indicate restriction 
enzyme sites; H = HindIII; E = EcoRI; D = DdeI; B = BstXI; S = Sau3A; RV = EcoRV; K = KpnI; Sa 
= Sac!. The arrows beneath restriction enzyme map indicate nucleotide sequence of pCIl generated 
from primers pUCF, pUCR, 96-24 and 96-25. The vector insert is cloned into pBIISK(+). Solid line 
represents size and position of probe obtained by PCR and used in Southern hybridisation. Solid 
boxes on line indicate hybridisation position of primers 96-24 and 96-25. Scale: lcm = 100 base 
pairs. 
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3.2.2 DNA SEQUENCING OF THE IpxA REGION OF C. jejuni. 
To determine whether the gene(s) responsible for restoration of the ability of KLC 
4177 to grow at 42°C was in fact ipxA, the nucleotide sequence of the C. jejuni 
F38011 insert contained in pcn was determined. 
DNA sequence from pcn was initially produced using universal primers pUC forward 
and pUC reverse (section 2.8) by Sanger dideoxy sequencing, as the insert was cloned 
into the pBIISK(+) vector. About 500-600 bp of sequence was obtained from both 
the forward and the reverse primer, however these nucleotide sequences were non-
overlapping at their respective 3' ends. From this C. jejuni F3 80 11 DNA sequence, 
oligonucleotide primers were constructed in order to obtain the DNA sequence from 
the middle region of the F38011 DNA insert in pcn (section 2.8). Lastly, sub clones 
were constructed from pcn, using EcoRI and HindUI partial digestions, solely for 
sequencing purposes, in order to tidy up the middle region of the insert (pCn 03 and 
pCnI2). 
The nearly complete sequence of the F38011 chromosomal DNA insert from pcn is 
shown in Figure 11. It consists of 792 nucleotides and has a G+C content of about 
30%, consistent with that reported for other C. jejuni genes . 
. 
DNAsis analysis of the sequence generated from C. jejuni F38011 revealed one 
complete open reading frame (ORF), and two partial ORFs. The sequence of the ipxA 
gene from E. coli K12 and other Gram-negative bacteria has been shown previously to 
consist of from 786 to 792 bp, encoding a protein ranging from 258 to 264 amino 
acids. In pCI 1, ipxA amino acid sequence appears to be transcribed and translated 
from the pUCF direction. 
DNA sequence from pcn was sent to the BLAST server to search for possible 
nucleotide sequence and amino acid similarities with other known DNA and amino 
acid sequences. Translated amino acid sequence from the pUC forward end of the 
DNA sequence revealed protein similarity to two genes: citrate synthase (cdh); and 
JabZ from E. coli, R. rickettsii, H. inJluenzae, Y. enterocolitica and S. typhimurium. 
Mohan et al.(1994) found significant homology between orJ17 (fabZ) and JabA 
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(encodes a dehydrase necessary for introduction of cis unsaturation into E. coli fatty 
acids) of E. coli which suggested that orjll also encodes a dehydrase, presumably one 
involved in saturated fatty acid biosynthesis. orfll has therefore been designated jabZ 
in E. coli. It is this gene,jabZ, that appears to be located directly upstream of lpxA in 
C. jejuni F38011. These open reading frames are transcribed in the same direction and 
this correlates with the order of genes in E. coli. In E. coli, the termination codon of 
jabZ, UGA overlaps with the start codon GUG of lpxA and it is thought that these 
genes may be translationally coupled (Coleman and Raetz 1988). This situation 
appears similar in F38011 (figure 11). 
BLAST analysis of F38011 DNA sequence revealed another incomplete ORF 
upstream of the putative jabZ sequence. This ORF displayed strong amino acid 
similarity to the citrate synthase gene from Bartonella spp., Rickettsia spp., 
Streptococcus spp. and Rhizobium spp. This gene appears to be a cloning artifact of 
the original C. jejuni F38011 plasmid expression library construction. This library was 
originally constructed by Sau3A partial digestions ligated into pBIISK(+). The citrate 
synthase gene in pcn is located solely on a 204 bp Sau3AJSau3A fragment. There is 
no evidence for linkage of citrate synthase with jabZ or IpxA in other organisms. 
Additionally, the open reading frame of the citrate synthase gene is located within the 
coding region ofjabZ and is apparently transcribed in the opposite orientation to jabZ 
and represents a central portion of the Cdh protein. 
Translation of nucleotide sequence nearest to the pUC reverse primer revealed no 
DNA sequence similarity to lpxA sequence from any other organism. The closest 
match was similarity to part of the Methanococcus jannaschii genome with a 
probability match of 0.07 5 (the closer to 1 the probability is, the more improbable the 
match is). However predicted amino acid sequence from the complete insert sequence 
displayed strong amino acid identity (beginning about 400 nucleotides from pUCF and 
ending about 220 nucleotides in from the pUCR primer) to the UDP-N-
acetylglucosamine acyltransferase protein (LpxA) of E. coli, S. typhimurium, R. 
rickettsii, Y. enterocolitica and Haemophilus inJluenzae, revealing the characteristic 
hexapeptide repeat motif observed in all other lpxA protein sequences to date (figure 
12). 
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ATGAGCAAAATGCTTCAACTTCAACAGTTCGTGCTGTGGGTTCAACTCATGCTCATCCTTATGCCTGTATAGCAGCAGGT 
GluGlnAsnAlaSerThrSerThrValArgAlaValGlySerThrHisAlaHisProTyrAlaCysIleAlaAlaGly 
90 100 110 120 130 140 150 160 
ATTGGTGCGCTTTGGGGTCATGCACATGGTGGAGCTAATGAAGGTGTTATTAGAATGCTTGAGCAAATAGGTAGTGTTGAT 
IleGlyAlaLeuTrpGlyHisAlaHisGlyG1yAlaAsnGluGlyValIleArgMetLeuGluGlnlleGlySerValAsp 
+--- cdh-------ll fabZ ---~ 
170 EcoRI 180 190 DdeI 200 Sau3A 210 220 230 240 
AGGGTAGATGAATTCATCAAAAGAGCTAAGGATAAAAACGATCCAAAAAGTAAAGTAGTTTATTTCACAGGCATAGATGGA 
ArgValAspGluPheIleLysArgAlaLysAspLysAsnAspProLysSerLysValValTyrPheThrGlyIleAspGly 
250 260 270 280 290 300 310 320 
GCAAAATTTAGAAATCCTGTGCGTCCTGGAGATAGGCTTGATTATGAAATGAGCGTGGTTAAAAATCGTGGTAATATGTGG 
AlaLysPheArgAsnProValArgProGlyAspArgLeuAspTyrGluMetSerValValLysAsnArgGlyAsnMetTrp 
HindIII lpxA -.. 
330 340 350 360 370 380 BstXl 390 400 
ATTTTTAAAGGGCAAGCTTTTGTAGATGGAAATTTAGTTGCAGAGGCCGAGCTTAAAGCCATGATAGTGGATAAATAATG 
IlePheLysGlyGlnAlaPheValAspGlyAsnLeuValAlaGluAlaGluLeuLysAlaMetIleValAspLys***** 
410 420 430 440 450 460 
HindIII 
470 
Met 
480 
AAAAAAATTCATCCAAGTGCGGTGATTGAACACGGTGCACAACTTGGTGACCATGTTGTATTAAAAGCTTATGCTTATGTA 
* 
LysLysIleHisProSerAlaValIleGluHisGlyAlaGlnLeuGlyAspHisValValLeuLysAlaTyrAlaTyrVal 
490 500 510 520 530 EcoRI 540 550 560 Sau3A 
AGCAAAGATGCTAAAATAGGTAATAATGTTGTCATCAAACAAGGTGCTCGAATTCTTTCAGATACAACTATAGGT.GATCAT 
SerLysAspAlaLysIleGlyAsnAsnValValIleLysGlnGlyAlaArgIleLeuSerAspThrThrIleGlyAspHis 
570 580 590 600 DdeI 610 620 630 640 
TCTCGTGTATTTTCTTATGCTATAGTAGGCGATATTCCTCAGGACATTATCTTATATCCAAGAGCCTATAAGGGTGTTATT 
SerArgValPheSerTyrAlaIleValGlyAspIleProGlnAspIleIleLeuTyrProArgAlaTyrLysGlyValIle 
650 660 670 680 690 700 710 720 7 
ATAGGGAAAAAGCAACTAATAGAGAATATAAGAGTGATAAATTCAGGTACAGTTAAAGGGAGATGTTTTACTAGTATAGGG 
IleGlyLysLysGlnLeuIleGluAsnIleArgValIleAsnSerGlyThrValLysGlyArgCysPheThrSerIleGly 
30 740 750 760 770 780 790 800 81 
GGTAATGCTTTTATTATGGATTATTGTCATATTGCTCATGATTGTATTTTAGGTAATAAATATTATTTTAGGAATAATGCA 
GlyAsnAlaPheIleMetAspTyrCysHisIleAlaHisAspCysIleLeuGlyAsnLysTyrTyrPh eAr gAs nAsnAla 
o 820 830 840 850 860 870 880 890 
ACTTTGGCAGGACATGTAGAGGTTGGAGATTTTACGGTTGTAGGCGGGCTTACACCTATTCATCAATTTGTCAAAGTAGGT 
ThrLeuAlaGlyHisValGluValGlyAspPheThrValValGlyGlyLeuThrProIleHisGlnPheValLysValGly 
900 910 920 930 940 950 960 970 
GAGGGTTGTATGATAGCAGGAGCAAGTGCACTTTACTCAGGATATAGAACAGTTTTGTTTAGCAGGGGAAATCGTGCAAGT 
GluGlyCysMetIleAlaGlyAlaSerAlaLeuTyrSerG1yTyrArgThrValLeuPheSerArgGlyAsnArgAlaSer 
980 990 1000 1010 1020 1030 DdeI 1040 1050 
ATTAGAAGTTTAAATTTAGTAGGTACTCGTCGTCGTTTTGATAAAGATGAAGTAGATAGACTTAGTAGAGCTTTTAAAACT 
IleArgSerLeuAsnLeuValGlyThrArgArgArgPheAspLysAspGluValAspArgLeuSerArgAlaPheLysThr 
1060 1070 1080 1090 1100 1110 1120 1130 
TTATTTAGACAAGGAGATTTAAAAGAAAATGCTAAAAATTTGCTTGAAAATCAAGAAAGTGAAAATGTTAAAAAAATGTGC 
LeuPheArgGlnGlyAspLeuLysGluAsnAlaLysAsnLeuLeuG1uAsnGlnGluSerGluAsnValLysLysMetCys 
1140 1150 1160 EcoRI 1170 1180 1190 1200 1210 
CATTTTATATTAGAAACAAAGCGTGGAATTCCTGTCTATAGGGGTAAAAATAATGCCTAGAAAATGTAGTTTTTGCAAT 
His PheI 1 eLeuGluThrLysArgGlyI 1 eProValTyrArgGlyLysAsnAsnAl a*** 
-+ 
oryX MetProArgLysCysSerPheCysAsn 
62 
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1220 1230 1240 1250 1260 1270 1280 1290 
GAAGTGGAGAATCCACAAAGAAGAATTTTAGCAAATGAAAATGATGATGCTTTTATTTGTGAATATTGCGTTGAAGGT 
G1uVa1G1uAsnProG1nArgArgI1eLeuA1aAsnG1uAsnAspAspA1aPheI1eCysG1uTyrCysVa1G1uG1y 
EcoRV 
1300 1310 1320 1330 1340 1350 1360 1370 
GCTTATAGTATTATTTATGGAGAAGAAAAAGAATTTAAAGAACCTAAACAAAGTTATAATACAGAATTTAAAGATATC 
A1aTyrSerI1eI1eTyrG1yG1uG1uLysG1uPheLysG1uProLysG1nSerTyrAsnThrG1uPheLysAspI1e 
HindIII Sau3A 
1380 1390 1398 
ACTCCAAAAGAATTAAAAGCTTATTTAGATC 3' 
ThrProLysG1uLeuLysA1aTyrLeuAsp 
63 
Figure 11. C. jejuni F38011 DNA sequence of peIl. The C. jejuni insert includes one complete 
open reading frame (ORF) and two partial ORFs with the possibility of a fourth putative ORF 
(ORFX). Restriction endonuclease sites within the insert are shown in bold and labelled accordingly. 
Arrows show the direction of transcription of the three ORFs; citrate synthase is transcribed in the 
opposite direction to JabZ and /pxA. A fourth ORF is thought to be present at the termination of the 
/pxA gene. There is speculation about whether ORFX is the /pxB gene and whether /pxB is coupled 
with the /pxA gene in C. jejuni, after the observation of this order of genes in E. coli. 
The mol % GC content of the lpxA gene of E. coli is around 50%, while the mol % 
GC content of the C. jejuni lpxA gene is approximately 30%. 
Sequence analysis did not reveal a putative promoter for lpxA; this may be because 
lpxA is transcribed together with jabZ, as suggested by the enteric bacteria. The 
initiation codon for the C. jejuni F38011 lpxA gene appears to be the standard AUG, 
and overlaps with the double termination codon of jabZ. In other organisms, the 
initiation codon of lpxA is not AUG but GUG (this would normally be the amino acid 
valine). The order of the genes jabZ and lpxA in C. jejuni F3 80 11 appears to be the 
same as that published for E. coli. No Sau3A restriction site occurs between the 3' 
end ofjabZ and the 5' end of lpxA in F38011, according to the sequence, indicating no 
cloning anomaly present. 
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MSKSMKETFiHPTALvEPGVEIGQGVSvGPFCHvQSGAliGNDCElMSHV 
MSN--SN--iHTTAViAEGAKIGKNVKiGPYCliGPEVVlNDNVElKSHV 
MID--KSAFiHPTAlvEEGASiGANAHiGPFClvGPHVEiGEGTVlKSHV 
MID--KTAViHPSSlvEEGAViGAGVHiGPFCFvGSQVEiGAGTElKSHV 
MID--KSAFiHPTAlvEDGAViGANAHiGPFClvGPQVEiGEGTVlKSHV 
MKK------iHPSAViEHGAQIGDHVV1KAYAYvSKDAKiGNNVViKQGA 
MIH--PSAKiHPTALiEEGAViGEDVFiGPFCliEGTVEiKARTVlKSHV 
* * * * 
ViTGATTIGAGTKvYPHAIIGCDPQNNKHKGGPTRLNvGVNCliREGVTm 
ViEGITEiGENTViYPGASiGQPPQILKYANERSSTliGSNNTiREYVTv 
VvNGHTKiGRDNEiYQFASiGEVNQDLKYAGEPTRVEiGDRNRiRESVTi 
VvNGITKiGCDNQiYQFASiGEANQDLKYAGEPTRVEiGDRNRiRESVSi 
VvNGQTKiGRDNEiYQFASiGEVNQDLKYAGEPTRVEiGDRNRiRESVTi 
RiLSDTTiGDHSRvFSYAlvGDI PQDI I LPRAYKGVI iGKKQLiENIRVi 
VvRGDTViGEDNEiYQFTSiGEVNQDLKYKGEATKTliGNSNKiREHVTi 
* * * * * * 
HKGSDNARGYTSiGDNCSFLAYAHvAHDCDiGGHYVTFSNNVMiGGHTSi 
QAGSQGGGMMTRvGNNNLFMVGVHiGHDCKiGNNVV-FANYVSIAGHIGv 
HRGTVQGGGLTKvGSDNLIMINAHiAHDCTvGNRCI-IANNATIAGHVSv 
HRGTVQGGGLSKvGSDNLiMINAHiAHDCliGDRCI-iANNATlGGHVEi 
HRGTVQGGGLTKvGSDNLIMINAHvAHDCTvGNRCI-IANNATIAGHVSv 
NSGTVKGRCFTSiGGNAFiMDYCHiAHDCIIGNKYY-FRNNATIAGHVEv 
HRGTIQGCGITAiGNNNLIMINVHvAHDCQiKNNCI-IANNATIAGHVEl 
* * * *** * ** 
GHHAIIGGGAAvHQFVRvGHHAFiGGLAAvVSDLIPYGMAIGVHAHLGGL 
GDYAliGGLSAvHQYARiGEYSMiGGLSPvGADVIPFGLVSSKRAVLEGL 
DDFAliGGMTAvHQFCliGAHVMvGGCSGvAQDVPPYVIAQGNHATPFGV 
DDFAliGGMTAiHQFCViGAHVMvGGCSGvAQDVPPFVIAQGNHATPFGI 
DDFAliGGMTAvHQFCliGAHVMvGGCSGvAQDVPPYVIAQGNHATPFGV 
GDFTVvGGLTPiHQFVKvGEGCMiAGASAIYSGYRTVLFSRGNRASIRSL 
DDFVlvGGMSAiHQFVlvGAHVMlGGGSMvSQDVPPYVMAQGNHARPFGV 
** ** * * * 
NIIGMKRSGMERKEIHNLRHAVRMLFDRTKPIRQRAQDVLAAIPDSPTVS 
NLIGMNRKGFDKVKSLSALKALEEIFSGEGNFAERIKQVAEKYNNNSIVI 
NIEGLKRRGFSREAITAIRNAYKLIYRSGKTLDEVKPEIAELAETYPEVK 
NIEGLKRRGFDKESLHAIRNAYKLLYRSGRTLDEVKPEIAELADQHPAVQ 
NIEGLKRRGFSREGLVAIRNAYKLLYRSGKTLDEAKLEIAELAEKHPEVK 
NLVGTRRR-FDKDEVDRLSRAFKTLFRQG-DLKENAKNLLENQESEN-VK 
NLEGLKRRGFDKPTMHVIRNIYKMLYRSGKTLEEVLPEIEQlAETDSAIS 
* * * 
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DMISFINVDTKRAYCTPPLDAAHGGAGHDSDED 
QIIDFLNQDSSRAFCRF--------------EK 
AFTDFFAR-STRGLIR-----------------
AFIDFFAR-STRGIIR-----------------
AFTEFFER-STRGPIR-----------------
KMCHFIL-ETKRGIPVY----------RGKNNA 
FFVEFFKR-STRGIIR-----------------
* * 
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Figure 12. Multiple amino acid sequence alignment of the UDP-N-acetyltransferases (lpxA) of 
Brucella abortus (Bab), Rickettsia rickettsii (Rri), Escherichia coli (Eco), Yersinia enterocolitica 
(Yen), Salmonella Iyphimurium (Sty), Haemophilus injluenzae (Hinf), with the putative 
Campylobacter jejuni (Cjej) IpxA gene. Identical residues are indicated by an *, conserved residues 
by a ., and dashes indicate regions of unobtained amino acid sequence (or gaps). Lower case letters 
show the conserved hexapeptide repeat observed in enteric organisms for IpxA (and seen in other 
genes (section 1.8.2.3». 
3.3. peR ANALYSIS. 
Due to problems encountered with importing the C. jejuni F38011 strain from the US, 
work shifted to a well-characterised C. jejuni clinical strain from the NZ collection, 
strain NZRM 1958. 
A PCR reaction was performed usmg the JabZ-lpxA pnmers 96-24 and 96-25, 
previously used for DNA sequencing of C. jejuni F38011 DNA (section 3.2.2). This 
experiment was designed to show that lpxA was found on the genome of C. jejuni 
NZRM 1958. For pcn and pCI4 plasmid DNA, and genomic DNA from lysed 
colonies of C. jejuni NZRM 1958, an approximately 800 bp PCR amplicon was 
observed using these two primers (Figure 13a). PCR amplicons generated from pcn, 
pCI4 and C. jejuni NZRM 1958 were restriction endonuclease digested with EcoRI 
and Hindlii in separate reactions. An identical restriction digestion pattern was 
observed for both strains of C. jejuni with either EcoRI and Hindll1 (Figures 13b and 
Be). To rule out amplification of the E. coli lpxA gene by the primers 96-24/96-25 in 
the plasmid peR samples, an E. coli control was performed. No PCR amplicon was 
generated in this experiment (figure 13 a). 
The 800 bp amplicon from C. jejuni NZRM 1958 was cloned into the PCR vector 
pGEM-T (pCI6) and the nucleotide sequence determined by Sanger dideoxy 
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sequencing using the pUC forward and reverse primers. Approximately 600 bp of 
sequence out of a possible 800 nucleotides was obtained. Nucleotide sequence was 
sent to the BLAST server, revealing amino acid similarity to the ipxA genes of H. 
injluenzae, R. rickettsii, S. typhimurium, Y. enterocolitica, E. coli and Brucella 
abortus. 
The putative ammo acid sequence translated from C. jejuni 1958 DNA sequence 
revealed the characteristic hexapeptide motif observed in the other LpxA proteins 
(Figure 14). This region shows clear amino acid sequence identity to the same region 
of the LpxA protein of strain F3 80 11, although noticeable differences are apparent as 
well. It should be noted that some of the NZRM 1958 sequence was most likely 
erroneous (note large gaps in Figure 14, part A). However, despite these gaps, 
sequence differences were still observed. 
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Figure 13. (A) Lane 1, 1 kb marker; Lanes 2-7 - PCR products resulting from primers 96-24 and 96-
25. In lane 2, the DNA template was a lysed colony of C. jejuni NZRM 1958; Lane 3, DNA template 
was a KLC 4177 lysed colony; Lane 4, DNA template was a lysed colony ofKLC 4178; Lane 5, DNA 
template was a lysed colony of KLC 4181; Lane 6, DNA template was pCIl plasmid DNA; Lane 7, 
DNA template was pCI4 plasmid DNA. For PCR conditions see Materials and Methods. (B) PCR 
products from (A) digested with EcoRI. Lane 1, 1 kb standard marker; Lanes 2-7 are the same as in 
(A). (C) PCR products from (A) digested with HindIII. Lane 1, 1 kb standard marker; Lanes 2-7 are 
the same as in (A). 
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GATCATTCTCCTCTATTTTCTTATTCTATACTACGTGATTTTCCTCAGGA 
GATCATTCTCGTGTATTTTCTTATGCTATAGTAGGCGATATTCCTCAGGA 
********** * *********** ***** ** * *** ******* ** 
CATT-TCTTATACACAATATCAAATTAGCGGTGTTGTTATTTGGAAAAAT 
CATTATCTTATAACCAAGAGCCTATAAGCGGTGTTATTATAGGGAAAAA-
**** ******* *** * * ** ********* **** ******* 
GCAACTTTTAAAAAATTTGC-ATCCATAAATTCAGGTTCACCTAAAGGAT 
GCAACTAATAGAGAATATAAGAGTGATAAATTCAGGTACAGTTAAAGGGA 
****** ** * *** * * ************ ** ****** 
ATGGTTTTACTCCTATATGCCATAATGCCTTTATTATCTCTTAATGTCAT 
GATGTTTTACTAGTATAGGGGGTAATGCTTTTATTATGGATTATTGTCAT 
******** **** * ****** ******** *** ****** 
ATTGCTCATGATTGTCTTTTATGTTATTA-TATTACTTTATCTCATAATG 
ATTGCTCATGATTGTATTTTAGGTAATAAATATTATTTTAGGA-ATAATG 
*************** ***** ** ** * ***** **** ****** 
CTACTTTGGCATGAC-TCTTCACCTTTCATATTTTACGGTTCTATGCTGC 
CAACTTTGGCAGGACATGTAGAGGTTGGAGATTTTACGGTTGTAGGCGGG 
* ********* *** * * * ** * *********** ** ** * 
CTCTCCCCTACTCATCAATTTGTCAAACTTTGTGATGGTTGTATCATACC 
CTTACACCTATTCATCAATTTGTCAAAGTAGGTGAGGGTTGTATGATAGC 
** * **** **************** * **** ******** *** * 
ACGAACAACTCCTCTTTCTCC------TCGGATAATCTTCCCTCTCTTTT 
AGGAGCAAGTGCACTTTACTCAGGATATAGAACAGTTTTGTTTAGCAGGG 
* ** *** * * **** * * * * * * ** * * 
T---TTCCCCAAACGAAAATCCCCCCACCTTTTTCTGAAAATTTCAATAT 
GAAATCGTGCAAGTATTAGAAGTTTAAATTTAGTAGGTACTCGTCGTCGT 
* *** * * ** * * * ** * 
TCCTAT-----TCTCGTTATTCTCCTTAGTCTTTTTTTTTCAATCTTCTT 
TTTGATAAAGATGAAGTAGATAGACTTAGTAGAGCTTTTAAAACTTTATT 
* ** * ** 
C---CCATTCTATCTTTCT 
TAGACAAGGAGATTTAAAA 
* * ** * 
* ** * **** ** ** ** 
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DHSPLFSYSILRDFPHDISYTQYQISGVVIWKNATFKKFASINSGSPKGY 
DHSRVFSYAIVGDIPQDIILPR-AYKGVIIGKKQLIENIRVINSGTVKGR 
*** *** * * * ** ** * * **** ** 
GFTPICHNAFIIS-CHIAHDCLLC--YYITLSHNATLA----LFTFHILR 
CFTSIGGNAFIMDYCHIAHDCILGNKYY--FRNNATLAGHVEVGDFTVVG 
** * **** *******.* ** ***** * 
FYAASPLLINLSNFVMVVS-------YHEQLLFLLGSSLSFFPQTKIPPP 
GLTPIHQFVKVGEGCMIAGASALYSGYRT-VLFSRGNRASIRSLNLVGT-
* * 
FSENFNIPILVILLPLFFSIFFPFYLS 
-RRRFDKDEVDRLSRAFKTLFRQGDLK 
* * * * * 
** * * 
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Figure 14. Comparison of C. jejuni 1958 and C. jejuni F38011 nucleotide (A), and amino acid (B) 
sequence from nucleotide 561 (amino acid 187) to nucleotide 1077 (aa 359) of C. jejuni F38011. 
* indicates identical amino acids or nucleotides; a full stop indicates conserved identities; and dashes 
indicate regions of unobtained amino acids or nucleotides ( or gaps). Bold letters indicate conserved 
hexapeptide repeat observed in LpxA in other enteric organisms. 
3.4 Southern Hybridisation Analysis of Two C. jejuni strains. 
Southern hybridisation analyses of plasmid DNA from C. jejuni strain F38011 and 
from genomic DNA obtained from C. jejuni strain NZRM 1958 were performed to 
confirm that the order of genes on the C. jejuni chromosome wasJabZ-lpxA, and that 
the genes were contained as a single copy on the C. jejuni genome. A probe was 
constructed from the PCR amplicon generated from genomic C. jejuni NZRM 1958 
DNA using the primers 96-24 and 96-25 (see section 3.3, figure 10). The probe was 
used to hybridise to C. jejuni NZRM 1958 genomic DNA that had been restriction 
endonuclease digested in separate reactions with EcoRI, HindIII and Pst} (data not 
shown). 
The probe was found to hybridise to two fragments in pcn digested with EcoRI 
(figure 15). These two EcoRI fragments, 700 bp and 500 bp were predicted based on 
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the deduced nucleotide sequence from lpxA of F3 80 11. The probe hybridised to three 
fragments in pCll digested with HindIII, a 900 bp fragment, a 400 bp fragment and a 
200 bp fragment. These three DNA fragments were also anticipated to be detected as 
predicted from the nucleotide sequence. A fourth HindIII fragment, of 150 bp, was 
anticipated but during DNA transfer it was apparently lost from the end of the blot and 
not therefore detected. 
Differences were observed in the Southern blot profile of pCI4 digested with EcoRI or 
HindIII when compared to pcn; in pCI4 the probe hybridised to two EcoRI 
fragments of 700 bp and 3 kb, and three HindIII fragments of 200 bp, 900 bp and 3 
kb. As in pcn a fourth HindIII fragment, of 150 bp, was anticipated for pCI4 but 
during DNA transfer it was apparently lost off the end of the blot and not detected. 
The differences observed between the number of fragments produced for each plasmid 
from digestions, and hybridised to in pcn and pCI4 suggest that the portion of the 
citrate synthase gene sequenced from pcn is not present in pCI4 and the orientation 
of the DNA insert in pCI4 is in the opposite direction to that of pcn. This is deduced 
from the EcoRI and HindIII digests of pCI4 compared to pcn. The only difference 
between pCI4 and pcn probe hybridisation from the HindIII digestions was a 450 bp 
fragment observed for pcn. This would be observed for pCI4 if the insert in pCI4 
was orientated in the same direction as for pcn. If the insert in pCI4 was orientated 
in the opposite direction to pcn no 450 bp fragment would be observed and a slightly 
larger vector band would be observed and hybridised to by the 96-24/96-25 probe. 
This is what was actually observed for pCI4. In the EcoRI digestions a common 
fragment was observed for both pcn and pCI4 at 700 bp. This fragment was 
hybridised to by the probe for both plasmids. This was expected from restriction 
mapping data. If the orientation of the F38011 insert in pCI4 is indeed in the opposite 
direction a fragment would be expected to be observed at approximately 3.2 kb. This 
is what was observed for pCI4. A fragment of a slightly smaller size (3 kb) was 
hybridised to but not strongly in pcn, indicating partially digested DNA. However 
for pCI4 a strong band is seen, suggesting more than just partially digested DNA. This 
also suggests that pCI4 contains more C. jejuni F38011 DNA downstream of lpxA 
than is apparent in pcn. Due to the number of restriction fragments originally seen 
for pCI4 from digestions with EcoRI and the observation that only two of these 
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fragments were hybridised to, a suggestion is made that there are two additional EcoRI 
restriction enzyme sites present downstream of lpxA in C. jejuni F3 80 11. This 
downstream region may include the start or contain the whole lpxB gene of C. jejuni if 
the order of genes continues as in E. coli. One EcoRI site observed in restriction 
endonuclease digestions in pcn is non-existent in pCI4. This would be expected if the 
citrate synthase gene was absent upstream ofjabZ, as the EcoRI site is in cdh. Faint 
hybridisation to fragments from pcn of approximately 3 kbp in size is an indication of 
partially digested plasmid DNA. Ambiguities are found in terms of insert size when 
comparing restriction mapping data and Southern blot material for pCI4. 
The hybridisation of the probe to a single PstI restriction fragment (approx. 10 kb) 
from C. jejuni NZRM 1958 chromosomal DNA suggests that the IpxA gene is located 
on the genome of this strain as a single copy. lpxA was predicted to lie on a single PstI 
fragment only as no PstJ fragment was present within the DNA sequence. A single 
large band was seen for an EcoRI fragment of digested chromosomal DNA (> 14 kb). 
This was partially unexpected (expected two fragments - a 700 bp fragment and 
another fragment as probe overlaps 700 bp on one side) as EcoRI digestion was 
expected to generate a fragment of 700 bp. The EcoRI restriction site (GAATTC) is 
not a frequent restriction site in C. jejuni, and though digestions were incubated at 
37°C for 5-7 hours, only a large EcoRI fragment was detected. This result was 
repeated two separate times. More conclusive evidence of the genomic DNA 
containing a single copy of the lpxA gene would be shown by a HindIII digest of C. 
jejuni NZRM 1958 genomic DNA. However difficulties were encountered in 
obtaining genomic DNA digested with HindIII (data not shown). A second Southern 
hybridisation was attempted with HindIII-digested genomic NZRM 1958 DNA and a 
band was observed at approximately l.0 kb. It was expected that more fragments 
would have been observed ranging in size from 150 bp upwards. More HindIII-
digested genomic DNA needs to be obtained and worked with. From this data the PstJ 
digest suggests one copy of the lpxA gene, but EcoRIlHindIIJ digests did not reveal 
additional information. 
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Figure 15. Southern hybridisation, Plasmid DNA from pCIl and pCI4 was digested with EcoRI and 
HindlII in separate digests and probed with an 800 base pair PCR amplicon generated using the 
F38011-derived primers 96-24 and 96-25, Lane 1, 1 kb marker; lane 2, C. jejuni NZRM 1958 
chromosomal DNA digested with EcoRI; lane 3, C. jejuni NZRM 1958 chromosomal DNA digested 
with HindlII; lane 4, , C. jejuni NZRM 1958 chromosomal DNA digested with PstI; lane 5, pCIl 
digested with EcoRI; lane 6, pCI4 digested with EcoRI; lane 7, pCIl digested with HindlII; lane 8, 
pCI4 digested with HindlII, Sizes (kb) of the bands shown in lanes 1-4 were estimated by comparing 
migration of plasmid DNA to that of the known 1 kb standard migration, 
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3.5 Bacterial Growth Curve Data. 
Measurements of bacterial growth (OD600 absorbance changes with respect to time) 
were performed over a ten hour period to determine whether the plasmid pcn was 
capable of complete restoration of the growth defect in KLC 4177. It was 
hypothesised that if complete restoration of the temperature sensitive defect of KLC 
4177 occurred, the replication of KLC 4178 would be restored to the level of KLC 
4176 (wild-type) as reported by Galloway and Raetz (1990). Intermediate levels 
would suggest incomplete restoration of E. coli LPS. 
Aliquots ofKLC 4176, KLC 4177 and KLC 4178 replicating exponentially at 30°C in 
LB broth were shifted to 42°C as per Galloway and Raetz (1990). Absorbance at 600 
nm was measured hourly. The KLC 4176 parent replicates to high cfus at both 
permissive and non-permissive temperatures (figure 16a). At 30°C both KLC 4177 
and KLC 4178 appeared to replicate on a par with KLC 4176 and therefore had 
optical density measurements comparable to that of the wild-type KLC 4176 (see 
figure 16a). Strain KLC 4177 failed to replicate at the non-permissive temperature of 
42°C as predicted. Analyses (at a confidence interval of 99% using Student's T-test) 
showed a significant difference in cell viability and optical density between KLC 4177 
and the wild-type E. coli K12 strain KLC 4176 at 42°C. The presence of a plasmid 
encoding the C. jejuni lpxA gene (pCn) restored high temperature growth and also 
presumably UDP-N-acetylglucosamine acyltransferase activity in KLC 4178 as seen by 
replication of KLC 4178 at 42°C. KLC 4178, containing F38011 lpxA did not 
replicate as well as KLC 4176 at 4 2°C (figure 16b), but it did replicate significantly 
better than KLC 4177 (confidence level of 99%), thus indicating that the C. jejuni 
lpxA is capable of restoring replication in the temperature-sensitive mutant. Cell 
viability of KLC 4178 at 42°C was also significantly better than KLC 4177 at 42°C. 
This was judged by plating efficiency (see section 2.3.1). 
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Figure 16a. Changes in optical density of E. coli K12 strains KLC 4176, KLC 4177 and KLC 4178 
at 30°C and 42°C with respect to time. Results are an average of triplicate measurements. Arrow 
indicates time of temperature shift. Solid symbols indicate strains at 30°C; hollow symbols indicate 
strains at 42°C. 
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Figure 16b. Colony forming units ofKLC 4176, KLC 4177 and KLC 4178 at 30°C and 42°C over a 
ten hour sampling period. Results are an average of triplicate samples. Solid symbols indicate strains 
at 30°C; hollow symbols indicate strains at 42°C. 
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3.6 SDS-PAGE Analysis of Proteins. 
SDS-PAGE analysis was performed to investigate proteins expressed from the plasmid 
pcn. Maxicell analysis (see materials and methods) using strains KLC 4026, 
KLC 4027 and KLC 4178, was performed in an attempt to observe the presence of 
unique polypeptide products produced from KLC 4178, a strain containing pcn. 
Analysis of KLC 4178 containing the plasmid construct pcn, displayed a protein 
profile no different to those of KLC 4026 and KLC 4027 (controls) (see figure 17). 
Protein expression was inconclusive and time limits prevented further analysis of the 
protein product. 
, 
45-0-
'If 
31,0-
1 2 3 4 5 6 7 8 9 10 
Figure 17. Coomassie-blue stained 12% SDS-PAGE gel showing proteins isolated from KLC 4026, KLC 4027, 
KLC 4178 and KLC 4181. Lane I, protein standard marker; lanes 2-5 show 20 III of sample loaded and lanes 7-
10 show 10 III of sample loaded. Lane 2, KLC 4026; lane 3, KLC 4027; lane 4, KLC 4178; lane 5, KLC 4181; 
lane 6, protein standard marker; lane 7, KLC 4026; lane 8, KLC 4027; lane 9, KLC 4178; lane 10, KLC 4181. 
Autorad picture not shown due to the fact that nothing was seen when the phospho imager screen was scanned 
and read. 
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CHAPTER IV. 
DISCUSSION. 
LPS is an integral part of the Gram-negative outer membrane and has been an object of 
intensive research during the last decade. The most extensive studies involving the 
genetics ofLPS biosynthesis have been carried out with E. coli K12, S. typhimurium 
LT2 and Salmonella minnesota. Lipid A is the most conserved portion of LPS with 
most of the variation either in the chain length of the glucosamine substituted fatty 
acids or the number and chain length of acyl oxyacyl substituted fatty acids. Various 
lipid A defective strains have been constructed and characterised (Raetz 1990), and 
such studies have demonstrated the importance of lipid A (required for cell viability 
and endotoxicity). In this study I have isolated and characterised a gene encoding an 
enzyme that is likely to be involved in the biosynthesis of the lipid A region of LPS in 
Campylobacter jejuni strains F38011 and NZRM 1958. 
4.1 Temperature-sensitive complementation studies. 
The lpxA gene product, UDP-N-acetylglucosamine acyltransferase is known in E. coli, 
S. typhimurium and a number of other Gram-negative organisms (both enteric and 
nonenteric) to be essential in lipid A biosynthesis (Galloway and Raetz 1990). A 
conditional-lethal mutant in UDP-N-acetylglucosamine acyltransferase has previously 
been generated in E. coli K12 using localised chemical mutagenesis. The mutant KLC 
4177 (SMI0l) contains no measurable residual LpxA activity at 42°C, is supersensitive 
to hydrophobic and some peptide antibiotics, has a low spontaneous reversion 
frequency at 42°C, and is strikingly defective in lipid A biosynthesis in vivo at 42°C. 
Coleman and Raetz (1988) have demonstrated that all the biochemical and phenotypic 
alterations of KLC 4177 are corrected by E. coli plasmids bearing lpxA alone. This E. 
coli lpxA- mutant provided us with a model with which to study the effect of 
acyltransferase deficiency on cell viability and allowed us to identify a gene from C. 
, ".- -.---.-~ .... ~.~"".-.-~ .. -----.. -'---'- - - - - - ----~ - -
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jejuni whose product is likely to be involved in the synthesis of at least one species of 
lipid A found in the LPS of C. jejuni. 
4.1.1 COMPLEMENTATION OF KLC 4177 WITH C. jejuni PLASMID 
EXPRESSION LIBRARY. 
Growth of the temperature-sensitive E. coli K 12 mutant strain, KLC 4177 containing a 
C. jejuni F38011 plasmid expression library at the non-permissive temperature, 
indicated that a gene (or genes) from this library was able to restore the lpxA- defect of 
KLC 4177. It was concluded initially from growth at 42°C that complementing 
activity was present in plasmids from C. jejuni F38011 which were able to complement 
the lpxA - defect in KLC 4177. 
KLC 4177 cells were transformed a second time with the complementing plasmids 
from C. jejuni F38011 to confirm that the C. jejuni expression plasmids were 
responsible for this cell viability. Control plates were incubated at 30°C to rule out 
spontaneous reversion. Reversion of the originallpxA- mutant is unlikely based on: 1) 
the IpxA allele in KLC 4177 has a low spontaneous reversion frequency, 2) KLC 4177 
transformed with pBIISK(+) failed to grow at the non-permissive temperature, and 3) 
secondary transformation showed the growth of all transformants at 42°C, (a result 
unexpected if KLC 4177 had reverted). As the KLC 4177 cells used for pBIISK( +) 
and pCn-5 transformations were used from the same source, it is unlikely that a 
reversion event occurred during cell competence stages. 
The fact that the plasmid pcn corrects the lpxA- defect in KLC 4177 as seen by 
growth at the previously non-permissive temperature of 42°C, suggests that it contains 
a gene whose protein has an homologous function to that of LpxA, the protein which 
performs the same function in the model organism, E. coli. Thus it was expected that 
this gene would also encode the enzyme UDP-GlcNAc acyltransferase in C. jejuni 
F38011. 
Four other plasmids were identified in this initial screen for C. jejuni ipxA. No 
common restriction enzyme fragment was seen in all these plasmids, however pCl4 had 
several HindlII fragments in common with pCl1, suggesting a common DNA fragment 
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between the two plasmids. It was also determined that pCl4 contains the lpxA analog 
as determined by PCR analysis. 
Plasmids pC12, pCB and pCIS were not worked with to any great extent due to time 
constraints, however these plasmids have not been dismissed as they all show one 
important feature - the ability to complement the temperature-sensitive defect of KLC 
4177. One suggestion for the absence of common restriction enzyme fragments is that 
the lpxA gene is not present in pC12, pCB and pCIS and the complementing activity is 
the result of a gene product other than LpxA. Another possibility for these three 
plasmids is that there could be more sequence present downstream of lpxA and no 
sequence present in the JabZ region of the insert for these plasmids. Sequence 
generated from the inserts within these plasmids would provide a great deal of 
information about whether the lpxA gene is present within these three clones, or 
whether another gene is present that is performing a similar function. One can 
speculate as to whether the production of another acyltransferase, such as the lpxD 
acyltransferase, is encoded within the inserts of pC12, pCB and pCIS. This 
acyltransferase, similar in structure and function to lpxA may be able to complement 
the lpxA defect if overexpressed. It is known however, that death of cells occurs in 
lpxA- lpxD+ E. coli strains. 
A reduced rate of growth was observed for one of the transformants growing at 42°C 
compared to that of the other four transformants. This transformant contained the 
plasmid pCB. One suggestion for the difference in growth rate may be due to 
provision of an alternative pathway for lipid A biosynthesis by this transformant. 
Bypass mutations for UDP-GlcNAc acyltransferase requirement could possibly be 
achieved by activation of a gene that codes for an isoenzyme, or by alteration of the 
regulation of the lpx/dnaE operon. Perhaps a bypass pathway allows a secondary 
protein to modify glucosamine by upregulating another acyltransferase. Another 
suggestion is that perhaps instead of altering a glucosamine molecule as in E. coli one 
is in fact altering a glucose as is the case for a lipid A species in C. jejuni and the 
glucose is serving instead as a substrate for LPS biosynthesis. More than one gene 
may be necessary for this step, and the insert in pCB is large enough to accommodate 
more than one gene. 
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Due to time constraints, further work was not carried out on this plasmid. To 
determine the differences between all the plasmids, biochemical analysis, for example 
thin layer chromatography (TLC), would need to be carried out. Also a larger number 
of complementing clones containing a plasmid could be analysed in order to ascertain 
whether or not extragenic bypass mutations of lpxA2 can be isolated. 
4.2 Transcription and Translation of C jejuni IpxA. 
Restriction enzyme mapping of one of the /pxA complementing plasmids, pcn, 
revealed that it contained a 1.5 kb insert from the C. jejuni F38011 genome. Sanger 
dideoxy sequencing revealed the presence of four open reading frames; three partial 
ORFs and one complete ORF. It appears that almost the entire lpxA gene has been 
sequenced in C. jejuni F3 80 11, however most of the nucleotide sequence remains to 
be confirmed (figure 18). 
At the nucleotide level, ORF3 (lpxA), showed no identity to any genes found in 
Genbank. This is not unusual given its strong AT-rich nature (70%). However at the 
polypeptide level it was shown that ORF3 displayed strong amino acid identity to the 
UDP-N-acetylglucosamine acyltransferase protein from the /pxA gene of E. coli, 
Haemophilus injluenzae, Rickettsia rickettsii, S. typhimurium and a number of other 
Gram-negative bacteria (probability of 3.8xlO-44 ; this is essentially the probability that 
this sequence has arisen by chance, therefore the further away from 1, the more likely 
the sequence is). This homology extended throughout the polypeptide sequence. An 
important identifying feature of the protein was the conservation of the 'isoleucine 
patch', a hexapeptide repeat motif that has been observed in all other LpxA protein 
sequences. This repeating hexapeptide motif consists of a conserved isoleucine, 
leucine, valine (or their equivalent methionine) residue being consistently repeated 
every six residues in a polypeptide sequence. This repeat is conserved at the 
polypeptide level for LpxA and other acyl and acetyl transferases and has also been 
termed 'the acetyltransferase motif. 
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Figure 18. The restriction map ofpCIl, estimated to be 4.5 kb, showing the orientation of the 1.5 kb 
Sau3A-Sau3A C. jejuni F38011 insert in pBIISK(+). Sequencing of the 1.5 kb C. jejuni insert 
revealed three ORFs - cdh, citrate synthase geneJabZ; and /pxA. The Ap resistance gene (Ap(R», 
encoded on pBIISK(+) is also shown. Restriction endonuclease sites are shown as deduced from 
sequencing and restriction enzyme mapping studies. E = EcoRI; H = HindIII; and S = Sau3A. 
Although there is conservation at the amino acid level between alleles of lpxA from 
various Gram-negative bacteria, the amino acids present in the hexapeptide repeat 
differ in their identities compared to those from E. coli. In C. jejuni it was observed 
that of the conserved amino acids in this motif, the predominant amino acid is 
isoleucine. This may be due to the greater AT content of C. jejuni genomic DNA. 
Isoleucine is an AT -rich amino acid whereas valine and glycine are GC-rich amino 
acids. A second lpxA allele from C. jejuni strain NZRM 1958 has revealed 
considerable nucleotide sequence differences between both alleles, however on an 
amino acid level, the sequences are conserved (54% similarity). This suggests that 
considerable nucleotide changes are acceptable as long as primary amino acid sequence 
does not change. There is 62% amino acid homology up to the first large patch of 
nucleotide non-homology. 
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The lpxA gene in E. coli is part of a complex operon that also includes jirA/lpxD 
(encodes an acetyltransferase involved in step 4 of lipid A biosynthesis), JabZ (encodes 
a dehydrase involved in saturated fatty acid biosynthesis), lpxB, dnaE (the catalytic 
subunit of DNA polymerase III), as well as at least 3 other additional open reading 
frames of unknown function. The entire operon has been sequenced in E. coli and S. 
typhimurium, but its natural regulation remains uncertain. Both lpxA and lpxB gene 
products have been overexpressed and purified to homogeneity in E. coli. NH2-
terminal protein sequencing has confirmed that lpxA and lpxB are structural genes in E. 
coli. 
The nucleotide sequence and subsequent translation revealed the presence of the JabZ 
gene upstream of lpxA in C. jejuni F38011, suggesting that the order of genes is the 
same as that in E. coli. No putative promoter was identified from the lpxA sequence 
data at our disposal for C. jejuni F38011. It is likely that lpxA is transcribed together 
withJabZ as is thought in E. coli (Coleman and Raetz 1988), and that the promoter is 
found upstream ofJabZ. Tomasiewicz and McHenry (1987) have found a functional 
promoter just upstream of dnaE, in ORF23 . It has yet to be determined whether this 
promoter is active in vivo or functions in concert with other promoters. In E. coli it 
has been reported that by clustering certain genes into operons, growth-rate-dependent 
functions will be coordinately expressed (Burton et al. 1983). It is thought that JabZ, 
lpxA, lpxB, and dnaE promoters may be part of such an operon, with possible internal 
promoters to conditionally decouple expression of certain genes (Coleman and Raetz 
1988). This may well be the case in C. jejuni. 
The initiation codon of the lpxA allele in C. jejuni, methionine, appears to be the same 
as that of E. coli. It also appears that the 3' end of JabZ overlaps the 5' initiation 
codon of lpxA, a similar situation that the two genes occupy in E. coli. It would be 
interesting to determine whether these two genes and others present in the operon are 
coupled transcriptionally or translationally in C. jejuni as suspected in E. coli. The 
JabZ and lpxA genes do not have to overlap as seen in R. rickettsii, where there are 6 
nucleotides separating the rickettsial ORF16 and lpxA genes (Shaw and Wood 1994). 
Sequence downstream of lpxA in the C. jejuni F3 80 11 insert in pcn did not show 
signs of homology to the lpxB gene or any other gene in the BLAST database across 
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the nearly 60 amino acids present. It would appear, from physical mapping with 
restriction endonucleases that plasmid pCI4 may contain enough sequence to 
determine whether it is present. 
It would be of interest to determine whether lpxB is present downstream of lpxA as in 
E. coli and whether jabZ/lpxA are part of a larger operon, or if they are present 
independent of other essential LPSIDNA replication genes. 
Translated, ORF2 revealed amino acid similarity with the jabZ gene present in many 
Gram-negative organisms. The whole gene is not present upon the insert within pCIl, 
but we are able to speculate about whether this indicates that the order of genes is 
conserved for jabZ and JpxA. Evidence for this comes from several sources; 1) 
sequence of ORF2 is similar to JabZ as indicated by BLAST; 2) PCR amplicon 
generation with the primers 96-24/96-25 (96-24 is found in the putative JabZ 
sequence); 3) PCR amplicon generation and sequence suggestsJabZ is also present in 
C. jejuni NZRM 1958 and linked to lpxA; and 4) Southern data suggested genetic 
linkages. 
In pCIl, thejabZ sequence is preceded by a Sau3A/Sau3A nucleotide fragment that, 
when translated had amino acid similarity to the citrate synthase gene from many 
organisms. This fragment of DNA is in the wrong orientation relative to JabZ, and it 
also encodes an internal portion of the citrate synthase enzyme. From this we 
conclude that the citrate synthase gene is unlikely to be positioned in the genome 
upstream of jabZ. From Southern blot analysis of the plasmid pCI4, NZRM 1958 
genomic DNA and physical mapping comparisons with pCI4 it has been suggested that 
this gene is an artifact of construction of the plasmid expression library and does not 
belong in the lpx operon. It is unknown whether the citrate synthase gene is essential 
for C. jejuni survival. However it is unlikely that a partial gene sequence will be of use 
to the organism. Also the portion of citrate synthase gene sequence that was 
generated is contained on a Sau3A/Sau3A fragment only. This does not produce a 
contiguous part of the gene, only the internal portion of citrate synthase is revealed. 
We would have expected to see the 3' end of the gene before the start ofJabZ. This 
was not observed from sequence data generated. 
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4.3 Protein Analysis. 
Protein expression analysis from pcn was attempted using maxi cells, but no unique 
polypeptides were revealed due to insufficiently radiolabelled polypeptides. We can 
only speculate on the level of protein expected. In E. coli K 12 the lpxA gene encodes 
a 28.0-kDa protein (Coleman and Raetz 1988). We would expect a similar sized 
protein from C. jejuni, based on conservation of amino acid sequence within these 
organisms. 
The enzyme UDP-GlcNAc acyltransferase is very specific for R-3-hydroxymyristoyl-
acyl carrier protein (ACP) as the acyl donor (Williamson et al. 1991). Several fatty 
acyl transferases with an absolute specificity for acyl-ACP are capable of converting 
UDP-GlcNAc to UDP-2,3-diacylglucosamine (Anderson et al. 1985~ Crowell et al. 
1986). This suggests that lpxA cannot be replaced in these organisms (figure 19). 
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Figure 19. Relationship of key precursors of fatty acyl, lipid A, and peptidoglycan biosynthesis. 
Three major cell envelope components arise from two key precursors of E. coli metabolism. UDP-
GlcNAc serves as the glucosamine source in both peptidoglycan and lipid A biosynthesis. The lipid A 
pathway begins with the acylation at the 3-0H moiety of the glucosamine ring of UDP-GlcNAc with 
R-3-hydroxymyristoyl derived from R-3-hydroxymyristoyl acyl carrier protein. The latter is also the 
precursor of palmitate residues found in membrane glycerophospholipids. Since the equilibrium 
constant for UDP-GlcNAc acylation is unfavourable, the second reaction of the lipid A pathway (the 
deacetylase) appears to function as the first committed step, and it may be regulated. Abbreviations: 
U, uridine; ACP, acyl carrier protein; PtdEtn, phosphatidylethanolamine (Adapted from Young et al. 
1995). 
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4.4 Bacterial Growth Curve Data. 
pcn containing a putative lpxA gene was capable of restoration of viability for KLC 
4177 at 42°C (construct KLC 4178). However this restoration is less complete when 
compared to KLC 4176. This could be due to low expression of lpxA from a 
pBIISK( +) promoter as lpxA appears not to have an endogenous C. jejuni promoter. 
Equally, the low expression may be due to lack of regulation of the protein or some 
other factor, as E. coli and Campylobacter are different organisms with different 
genetic histories. A third possibility is that pcn "lpxA" is not lpxA, but a gene whose 
product may acylate GlcNAc at a low, but measurable rate. This last hypothesis would 
mean that, although the C. jejuni F3 80 11 insert in pCll contains a gene whose product 
has the characteristic hexapeptide motif and amino acid sequence extremely similar to 
LpxA, presence of this is not enough to qualifY the gene as lpxA. 
An interesting observation was made in that for the last couple of hours of sampling a 
slight increase in optical density measurements was seen for KLC 4177 at 42°C. 
Perhaps this is an indication of KLC 4177 lpxA- revertants regaining acyltransferase 
activity. However, there was no increase in optical density comparable to that of the 
wild-type strain as observations past the 10 hour recording period revealed (data not 
shown). The growth curve would need to be performed again over a longer time 
interval to see if there is any significant change in the absorbance of KLC 4177 with an 
increased amount oftime, or if the changes observed previously were just coincidental. 
Assays measuring lipid A synthesis in vivo, and UDP-N-acetylglucosamine 
acyltransferase activity in vitro could also be tested. 
The fact that only conditional-lethal mutations of lpxA may be obtained suggests that 
the lipid A present in E. coli is essential for growth and replication, probably because it 
is required for outer membrane assembly. Whether an lpxA- defect in C. jejuni would 
have the same effect upon the viability of the organism remains to be seen as three 
different lipid A molecules are proposed to be present in C. jejuni. However, perhaps 
like Rhizobium, the first steps of lipid A biosynthesis are identical while the remaining 
steps vary (eg. result in GlcNAc modification to 2-deoxy-2-aminogluconic acid). 
Chapter IV Discussion 86 
4.5 Future aims. 
Future aims include the creation of a null mutation in the lpxA gene in C. jejuni by 
insertion of a kanamycin resistance cassette into the lpxA allele from C. jejuni strain 
NZRM 1958 and gene replacement onto the NZRM 1958 chromosome by 
homologous recombination. Viability of C. jejuni would be assessed to determine if 
the lpxA gene is essential. Thin-layer chromatography would be used to assess the 
production of all three lipid A species in C. jejuni, or if only a subset of lipid A 
molecules are produced. These experiments would allow testing of the essential nature 
of lpxA in C. jejuni, the function of LpxA (assay for acyltransferase activity), and 
provide insights into lipid A biosynthesis in C. jejuni. 
In summary, the goals of this study were to identifY whether an lpxA analog existed in 
C. jejuni by functional analysis. Additionally, once identified, characterisation of the 
complementing activity was to be undertaken. Clearly these objectives have been 
achieved - pcn (and 4 other plasmids) allow growth of the temperature-sensitive 
lpxA- strain KLC 4177 at the non-permissive temperature. The C. jejuni nucleotide 
insert of pcn was sequenced and a putative lpxA gene was identified. The lpxA gene 
appears to be transcriptionally coupled to jabZ, the gene upstream of lpxA. Southern 
analysis revealed the presence of this transcriptional unit as a single copy on the C. 
jejuni genome. Future lipid A genetic and biochemical studies will benefit from the 
information contained in this thesis. 
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APPENDIX I. Media. 
I. i. General Media. 
Unless otherwise stated, all media are sterilised by autoclaving for 20 minutes at 120 kPa 
at 121°C. Solutions that were unstable at these high temperatures were filter sterilised 
through a 0.22 11m filter and added to media after autoclaving. 
Luria Bertani Media (LB) 
1.0% w/v bactotryptone 
0.5% w/v yeast extract 
0.5% w/v NaCI 
per litre 
10 g 
5g 
5g 
Made up in dH20, pH adjusted to 7.4 with NaOH before autoclaving. 
LB Agar (LBA) 
LB media with addition of 1.5% agar. 
I. ii. Specialised Media. 
M63Medium. 
1.36% w/v KH2P04 
0.2% w/v ~)2S04 
5 X 10-4% w/vFeS04.7H20 
per litre 
15 g 
per litre 
13.6 g 
2g 
0.5 mg 
Made up in dH20. pH was adjusted to 7.0 with KOH. After autoclaving, 10 ml of 20 % 
glucose was added as the carbon source. Also added was 1 ml of MgS04.7H20, 
vitamins ego thiamine (B 1) in the final concentration of 1 J.lg/ml and amino acids were 
added at a concentration of Ix in the L-form (see 100x stock concentration below). 
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M9 Minimal Salts Media (MM). 
0.6% w/v Na2HP04 
0.3% w/v KH2P04 
0.05% w/v NaCI 
0.1 % w/v N&CI 
per litre 
6g 
3g 
0.5 g 
1 g 
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Made up in dH20. After autoclaving, 10 ml 0.01% CaCh and 1 ml 1M MgS04.7H20 
were added as well as 10 ml of 20% glucose as the carbon source. Amino acids were 
added at a concentration of Ix (see 100x stock concentration below (L-form». 
Table 5: Amino acid supplements for minimal medium (lOOx stock solutions) . 
... ~~~~ .. A~~.~~ ................................................................................. ~g(~ ........................................... : ................................................ . 
L-alanine 2 
L-arginine 2 
L-asparagine 2* 
L-aspartic acid 10* 
L-cysteine 2* 
glycine 2 
L-glutamine 2 
L-glutamic acid 10 
L-histidine (free base) 2 
L-isoleucine 3 
L-Ieucine 3 
L-Iysine 3 
L-methionine 2 
L-phenylalanine 5 
L-proline 2 
L-serine 37.5 
L-threonine 20 
L-tryptophane 2* 
L-tyrosine 3* 
L-valine 10 
* = filter sterilised. All other amino acids were autoclaved. Amino acids were dissolved in dH20 unless 
otherwise stated. 
THE LIBRARY 
UNIVERSITY OF CANTERBURY 
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Appendices Appendix 1: Media 
Mueller-Hinton Agar 
300 g beef infusion 
17.5 g acid hydrolysate of casein 
1.5 g starch 
17 g bacto-agar 
Made up to 1 litre in dH20. pH 7.4 +/- 0.2. 
Campylobacter Blood-Free Selective Agar Base (Modified CCDA-Preston) 
per litre 
2.5% w/v Oxoid Nutrient broth no. 2 
0.4% w/v bacterial charcoal 
0.3% w/v casein hydrolysate 
0.1 % w/v sodium desoxycholate 
0.025% w/v ferrous sulphate 
0.025% w/v sodium pyruvate 
25 g 
4g 
3g 
1 g 
0.25 g 
0.25 g 
1.2% w/v agar 12 g 
In 1 litre dH20, pH adjusted to 7.4 before autoclaving. After autoclaving 1 ml of 
cefoperazone solution (3.2g/L) was added. 
Casein Hydrolysate (ACID) Vitamin Free (Casamino Acid Substitute). 
7.6 % w/w total nitrogen 
4.9 % w/w amino nitrogen 
28.3% w/w NaCI 
<0.1 % w/w tryptophan 
Made up as a 1% solution in dH20. pH adjusted to 7.0. 
100 
Appendices Appendix II: Buffers and Solutions 
APPENDIX II. Buffers and Solutions. 
II. i. Common Buffers. 
Solutions requiring sterilisation were either autoclaved for 20 minutes at 120 kPa at 
121°C or filter sterilised through a 0.22 /lm filter. 
TE 
10 mM Tris-HCI 
1 mMEDTA 
Made up in dH20; pH adjusted to 8.0 and the solution filter sterilised or autoclaved. 
SOx TAE 
50 mM Tris base 
0.11 % v/v glacial acetic acid 
1 mM EDTA (pH 8.0) 
Made up in dH20 to 1 L and the pH adjusted to 8.0. 
lxTAE 
20 ml of 50 x TAB made up to 1 litre with dH20. 
10 x TBE 
50 mM Tris base 
50 mM Boric acid 
1 mMEDTA 
Made up in dH20 to lL; pH adjusted to 8.0. 
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DNA Loading Dye for Agarose Gel Electrophoresis 
30% Glycerol 
0.25% Bromophenol blue 
0.25% Xylene cyanol FF 
Made up in dH20. 
II. ii. Specific Buffers and Solutions. 
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ll. ii. a. ALKALINE LYSIS OF BACTERIAL CELLS: EXTRACTION OF PLASMID 
DNA. 
The following solutions were filter sterilised, as necessary. 
Solution 1 (stored at 4°C) 
50 rnM glucose 
25 rnM Tris-HCI (pH 8.0) 
10 rnMEDTA (pH 8.0) 
+ sterile dH20 to 20 m!. 
Solution II 
1% SDS 
0.2NNaOH 
+ sterile dH20 to 20 mI. 
Solution ill (stored at 4°C) 
12 ml of 5 M potassium acetate 
8.7 % glacial acetic acid 
+ sterile dH20 to 20 mI. 
Resulting solution is 3 M with respect to potassium and 5 M with respect to acetate. 
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II. ii. h. CHROMOSOMAL DNA PREPARATION SOLUTIONS. 
The following solutions were filter sterilised. 
Solution I 
50 mM glucose 
50 mM Tris-HCI (pH 8.0) 
50mMEDTA 
10 mg/mllysozyme (added freshly before use) 
dH20 was added to 20 ml. 
Solution II 
50 mM Tris-HCI (pH 8.0) 
50mMEDTA 
I%SDS 
50 Ilg/ml proteinase K (added fresh before each use) 
dH20 was added to 20 mI. 
II. ii. c. SEQUENCING POLYACRYLAMIDE GEL SOLUTIONS. 
Sequagel Concentrate 
23.75% acrylamide 237.5 g 
1.25% methylene bisacrylamide 12.5 g 
(ratio of acrylamide to bisacrylamide is 19: 1) 
50% urea (8.3 M) 500 g 
Made up to 1 L in dH20. 
Sequagel Buffer 
50% urea (8.3 M) 
Made up to 1 L in lOx TBE. 
500 g 
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Sequagel Diluent 
50% urea (8.3 M) 
Made up to 1 L in dH20. 
Sequencing Gel 
500 g 
5% acrylamide sequencing gels were usually used for DNA sequence analysis. The 
following volumes were used: 
Sequagel concentrate 
Sequagel diluent 
Sequagel buffer 
10% APS - freshly made in dH20 
TEMED 
Final volume 
Dye for sequencing gels 
98% deionized formamide 
10 mM EDTA (pH 8.0) 
0.025% xylene cyanol FF 
0.025% bromophenol blue 
Sequencing Gel Fixer 
10% acetic acid 
10% isopropanol 
In dH20. 
20 ml 
70 ml 
10ml 
800 III 
40 III 
100 ml 
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II. ii. d. SDS-PAGE GEL ELECTROPHORESIS FOR PROTEINS. 
Separating Gel 
To make a 12% acrylamide separating gel, the following volumes of solutions were 
mixed to a total volume of 40 mi. 
4 x lower buffer 
acrylamide stock* 
H 20 
10% ammonium persulphate (fresh in dH20) 
TEMED 
30:0.8 acrylamide:bis-acrylamide 
Stacking Gel 
10.0 mI 
16.0 mI 
13.8 mI 
0.2m1 
10 III 
To make a 3% acrylamide stacking gel, the following volumes of solutions were mixed 
to a total volume of 10 mi. 
4 x upper buffer 
acrylamide stock 
H20 
10% ammonium persulphate (prepared fresh) 
TEMED 
Acrylamide stock 
acrylamide 
2.5 ml 
1.0 ml 
6.4 ml 
0.2ml 
4.5 III 
300 g 
bisacrylamide 8 g 
dH20 up to 1 litre. Filter through a 0.45 Ilm filter. Store at 4°C. 
10% SDS 
sodium dodecyl sulphate (SDS) 10 g 
dH20 up to 100 mi. Store at room temperature. 
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4 x Lower Buffer (1.5 M Tris-Hel, pH 8.8,0.4% SDS) 
Tris base 181.7 g 
10% SDS 40 ml 
dH20 up to 1 litre. Adjust the pH to 8.8 with Hel. Add 1 mlofTEMED. 
4 x Upper Buffer (0.5 M Tris-Hel, pH 6.8,0.4% SDS) 
Tris base 60.6 g 
10% SDS 40 ml 
dH20 up to 1 litre. Adjust pH to 6.8 with Hel. Add 2 ml ofTEMED. 
0.1% BpB 
bromophenol blue 
H20 
Store at room temperature. 
2 x Sample Buffer (SB) 
4 x upper buffer 
glycerol 
dH20 up to 60 mI. 
2 x Loading Buffer (LB) 
f3-mercaptoethanol 
O.I%BpB 
10% SDS 
2xSB 
4 x Running Buffer Stock (RBS) 
Tris base 
glycine 
dH20 up to 5 litres. 
10mg 
lOmI 
12.5 ml 
20.0 ml 
0.5 ml 
0.25 mI 
4.0 mI 
5.3 mI 
60.0 g 
288 g 
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1 x Running Buffer (1 x RB) 
4xRB 
H20 
10% SDS 
Stain 
isopropanol 
acetic acid 
H20 
Coomassie brilliant blue (R250) 
Destain 
methanol 
acetic acid 
dH20 added to 20 litres. 
1 litre 
3 litres 
40 rnl 
125 ml 
50 ml 
325 ml 
l.25 g 
1 litre 
1.4 litres 
ll. ii. e. SOUTHERN HYBRIDISATION SOLUTIONS. 
Depurination Solution 
0.2MHCI 
Denaturation Solution 
0.5MNaOH 
l.5 MNaCI 
Neutralisation Solution 
1 M Tris-HCI, pH 7.5 
l.5MNaCI 
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20 x sse 
3 MNaCI 
0.3 M Trisodium citrate. 
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In dH20 and pH adjusted to 7.2 with citric acid. This solution served as a stock of SSC 
and thus subsequent dilutions were made using this stock and dH20. 
Transfer Solution 
20 x SSC, pH 7.0 
Maleic Acid Buffer 
0.1 M maleic acid 
0.15 MNaCI 
pH adjusted to 7.5. 
lOx Blocking Solution 
10% blocking reagent 
90% maleic acid buffer 
Stored at 4°C. 
Detection Buffer 
0.1 M Tris-HCI 
0.1 MNaCI 
50mMMgCh 
Standard Hybridisation Buffer 
5 x SSC 
0.1 % N-Iauroylsarcosine 
0.02% SDS 
1 % lOx blocking reagent 
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Post-Hybridisation Wash I 
2xSSe 
0.1% SDS 
Post-Hybridisation Wash II 
0.1 sse 
0.1% SDS 
109 
Appendices Appendix III: Blast Sequence 
Appendix III. Blast Sequence 
>spIP10440ILPXA_ECOLI ACYL-[ACYL-CARRIER-PROTEINj--UDP-N-ACETYLGLUCOSAMINE 
O-ACYLTRANSFERASE (UDP-N-ACETYLGLUCOSAMINE ACYLTRANSFERASE) 
>pirl IXUECDP acyl-[acy1-carrier-proteinj--UDP-N-acetylg1ucosamine 
O-acyltransferase (EC 2.3.1.129) - Escherichia coli >gi1146661 
(M19334) acy1-[acy1 carrier proteinj--UDP-N -acetylg1ucosamine 
O-acyltransferase [Escherichia colij >gnl1PIDld1012622 (D83536) 
O-acyltransferase [Escherichia colij 
Length = 262 
Plus Strand HSPs: 
Score = 243 (111.8 bits), Expe8t = 3.8e-44, Sum P(3) = 3.8e-44 
Identities = 48/122 (39%), Positives = 70/122 (57%), Frame = +1 
Query: 646 VIIGKKQLIENIRVINSGTVKGRCFTSIGGNAFIMDYCHIAHDCILGNKYYFRNNATLAG 825 
V IG +.1 1+ G'l'V+G T +G + +M HIA DC +GN+ NNATLAG 
Sbjct: 84 VEIGDRNRIRESVTIHRGTVQGGGL'l'KVGSDNLLMINAHIADDCTVGNRCILANNATLAG 143 
Query: 826 HVEVGDFTVVGGLTPIHQFVKVGEGCMIAGASALYSGYRTVLFSRGNRASIRSLNLVGTR 1005 
HV V DF ++GG+T +HQF +G M+ G S + + ++GN A+ +N+ G + 
Sbjct: 144 HVSVDDFAIIGGMTAVHQFCIIGAHVMVGGCSGVAQDVPPYVIAQGNHATPFGVNIEGLK 203 
Query: 1006 RR 1011 
RR 
Sbj ct: 204 RR 205 
Score = 115 (52.9 bits), Expect = 3.8e-44, Sum P(3) = 3.8e-44 
Identities = 20/68 (29%), Positives = 38/68 (55%), Frame = +3 
Query: 
Sbjct: 
Query: 
Sbjct: 
414 IHPSAVIEHGAQLGDHVVLKAYAYVSKDAKIGNNVVIKQGARILSDTTIGDHSRVFSYAI 593 
+HP+A++E GA +G + + + V +IG V+K + T IG + ++S A 
8 VHPTAIVEEGASIGANAHIGPFCIVGPHVEIGEGTVLKSHVVVNGHTKIGRDNEIYSVAS 67 
594 VGDIPQDI 617 
+G++ QD+ 
68 IGEVNQDL 75 
Score = 58 (26.7 bits), Expect = 2.6, Sum P(2) = 0.92 
Identities = 11/39 (28%), Positives = 20/39 (51%), Frame +1 
Query: 724 SIGGNAFIMDYCHIAHDCILGNKYYFRNNATLAGHVEVG 840 
SIG NA I +C + +G +++ + GH ++G 
Sbjct: 19 SIGANAHIGPFCIVGPHVEIGEGTVLKSHVVVNGHTKIG 57 
Score = 58 (26.7 bits), Expect = 2.6, Sum P(2) = 0.92 
Identities = 14/46 (30%), Positives = 18/46 (39%), Frame +1 
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Query: 760 HIAHDCILGNKYYtRNNATLAGHVEVGDtTVVGGLTPIHQrYKVGE 897 
HI CI+G L HV V T +G 1+ +GE 
Sbjct: 25 HIGPtCIVGPHVEIGEGTVLKSHVVVNGHTKIGRDNEIYSVASIGE 70 
Score = 49 (22.5 bits), Expect = 3.8e-44, Sum P(3) = 3.8e-44 
Identities = 8/30 (26%), Positives = 16/30 (53%), trame = +1 
Query: 1003 RRRtDKDEVDRLSRAtKTLtRQGDLKENAK 1092 
RR t ++ + + A+K ++R G + K 
Sbjct: 204 RRGtSREAITAIRNAYKLIYRSGKTLDEVK 233 
Score = 40 (18.4 bits), Expect = 7.3e-29, Sum P(3) = 7.3e-29 
Identities = 9/39 (23%), Positives = 20/39 (51%), trame = +3 
Query: 486 VSKDAKIGNNVVIKQGARILSDTTIGDHSRVtSYAIVGD 602 
+ K A + ++++GA I ++ IG V + +G+ 
Sbjct: 2 IDKSArYHPTAIVEEGASIGANAHIGPtCIVGPHVEIGE 40 
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